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Mycobacterium tuberculosis is a bacterial pathogen that causes tuberculosis, a leading cause
of human death worldwide from infectious diseases, especially in Africa. Despite enormous
advances achieved in recent years in controlling the disease, tuberculosis remains a public
health challenge. The contribution of existing drugs is of immense value, but the deadly
synergy of the disease with Human Immunodeficiency Virus (HIV) or Acquired Immunod-
eficiency Syndrome (AIDS) and the emergence of drug resistant strains are threatening to
compromise gains in tuberculosis control. In fact, the development of active tuberculosis is
the outcome of the delicate balance between bacterial virulence and host resistance, which
constitute two distinct and independent components. Significant progress has been made
in understanding the evolution of the bacterial pathogen and its interaction with the host.
The end point of these efforts is the identification of virulence factors and drug targets
within the bacterium in order to develop new drugs and vaccines for the eradication of
the disease. However, a major limitation has been the high proportion of uncharacterized
proteins encoded by the genome. In this thesis, we have integrated biological data from
different sources for analyzing the unknown genes of Mycobacterium tuberculosis using the
functional network produced.
Three main contributions to the field can be identified in this thesis. First we set up a
data-driven scoring scheme for sequence and microarray data in order to fill gaps found in
the existing and commonly used functional networks for this specific organism. Second we
perform a functional analysis of the network produced through function prediction, where
possible, of proteins labelled ‘uncharacterized’ in the organism using Gene Ontology (GO)
terms. To this end, we set up a novel GO semantic similarity metric for comparing terms












to the curation of the proteome of this organism. Finally, we analyze the structure of
the functional network to elucidate proteins essential to the functioning of the system,
potentially contributing to the survival of the bacterium within the host and allowing the
bacterial pathogen to prosper. These proteins are potential drug targets, and can be used
to enhance the discovery process of new drugs in order to overcome this public health
challenge. Drug targets have been traditionally identified through complete knowledge of
individual proteins and their well characterized functions. Here, we integrate biological
data from different sources into a single functional network to provide a systems view of
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Throughout history, infectious diseases caused by microbial pathogens have been a scourge
for mankind. Their devastating impacts on human morbidity and mortality remain of
great concern, even today. With the advance of new high throughput sequencing tech-
nologies, there has been an increase in the number of worldwide microbial genome se-
quencing projects (http://microbialgenome.org, http://www.ncbi.nlm.gov/genomes/
MICROBES/Complete.html, http://www.sanger.ac.uk/Projects/Microbes and http:
//www.tigr.org/tdb/mdbcomplete.html), which has yielded complete genome sequences
of crucial microbial pathogens of humans, animals and plants. Analyses of these genome
sequences have provided valuable insights into the dynamics driving pathogenic mecha-
nisms and numerous virulence factors, and have shed light on the targeted organism’s
biology [2]. The character stic features of pathogenic organisms include their ability to col-
onize a specific host organ or tissue, to adapt to their environment, and to evade the host
immune response [3], thus leading to the development of disease, as a result of a delicate
and dynamic balance between pathogen and host defence system.
The genome sequences allow the analysis of organisms, facilitating the identification of
the genetic differences between several genomes from the same species, with the potential
to generate information and knowledge about functional interactions between genes in an
organism and genome relatedness [4]. Furthermore, the availability of these pathogenic
microbial genomes can contribute to speeding up the process of drug target selection [5] by
finding genes that are essential to microbial cell survival or growth and virulence. In fact,











Chapter 1. Introduction 2
major infectious diseases [6]. However, these efforts are weakened by an increased incidence
of widespread drug-resistant strains to the available and commonly used antibiotics and
vaccines, a growing prevalence of infections, and the emergence of new pathogenic organ-
isms, making infectious diseases the leading cause of human death worldwide. Tuberculosis
(TB) constitutes the biggest component of these infectious diseases, which claimed 1.8 mil-
lion victims in 2008 and there were estimates of 9.4 million new cases that year (3.6 million
of whom are women), including 1.4 million cases among people living with Human Immun-
odeficiency Virus (HIV) or Acquired Immunodeficiency Syndrome (AIDS) according to the
World Health Organization (WHO) [7, 8].
1.1 Pathogenesis and Virulence of MTB
TB is caused by an intracellular pathogen Mycobacterium tuberculosis (MTB), also known
as tubercle or Koch’s bacillus, whose genome sequence has been completely elucidated [1,
9, 10]. The progression of an MTB infection to disease is triggered by its virulence and
pathogenesis, which mainly depend on the response of the host immune system and the size
of the infecting dose of MTB [11]. Virulence is the mechanism by which microbes evade
the host immune response [12] while pathogenesis is the ability of microbial pathogens to
cause disease in their host. These processes are achieved through molecular interactions
between specific microbial products and host cells [13]. This leads to modification of host
cell functioning, thus allowing the parasite to invade host organs and tissues to ensure the
parasite’s survival, and resulting in disease in the host.
To control the growth of an MTB infection, the host engages a strong cell-mediated im-
mune response, releasing interferons (IFNs) secreted by the CD4+ T lymphocytes to allow
macrophages to overcome the parasite [14]. The activated macrophages secrete tumour
necrosis factor alpha (TNF-α), which promotes and stabilizes granuloma formation and
apoptosis (programmed cell death) [15]. Thus, the infection is cordoned off but the bac-
teria can survive extracellularly in a latent or dormant state [16], as granulomas are not
sterilizing structures. These granulomas may heal or enlarge and shed bacteria into the
blood stream and lymphatic system, or alternatively they may liquefy or form a cavity, re-










Chapter 1. Introduction 3
of the bacterium [17].
Infection occurs by inhaling infected droplets released by an individual with untreated pul-
monary TB via coughing, sneezing, talking or singing [18]. MTB is an airborne pathogen [19]
in its spreading mechanism, and these infected droplets can remain in the air for a long
period of time. They can be killed by ultraviolet light, including sunlight, but they can
survive in a dark and unventilated environment for several hours. Thus, the chance of TB
transmission depends on the number of MTB expelled into the air, the environment (light
or humidity), the closeness of contact, the immune status of the host and the virulence of
the bacteria.
On the MTB side, mechanisms are triggered to modulate the host response. These mech-
anisms include the down-regulation of antigen molecules [20], IFN-γ-mediated activation
of macrophages [21], and host cell apoptosis [22]. In fact, the host immune response is
initiated inside the phagosome and ends inside the phagolysosome [23]. To overcome the
host immune response, MTB first thwarts the maturation of the phagolysosome by stop-
ping the fusion of its phagosome with lysosomes [24]. A cell wall associated glycolipid,
mannosylated lipoarabimannan (ManLAM) found in MTB attenuates expression of TNF-
α and interferes with the recruitment of early endosome auto-antigen 1 (EEA1), a molecule
involved in endosome-endosome fusion, leading to the failure of phagolysosome fusion [25].
It has also been shown that MTB uses multiple receptors including complement recep-
tors 1 and 3 to break the border of host cells [26] and produces catalase (KatG) and
super-oxide dismutase (SOD) enzymes to deteriorate reactive oxygen intermediates it is
exposed to [27, 28]. The inactivation of the gene for catalase peroxidase, KatG, may lead
to the attenuation of growth of the bacillus [2]. Thus, understanding the molecular basis
of mycobacterial virulence depends on the identification of genes and gene products that
contribute to the pathogenesis, and the challenge is to optimally use available biological
data for accelerating the identification of new virulence factors.
In TB, the bacteria mainly affect the lungs, where they are initially ingested by pulmonary
macrophages and undergo intracellular multiplication, and where infection starts. They
can switch from an active to dormant state, called a latent state, in which case the infected
person does not suffer from TB. In the 1890s, Robert Koch demonstrated that the tubercle
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disease mainly results from excessive cell-mediated immune and inflammatory responses
mounted by the host in response to bacterial antigens. Therefore, disease occurs when the
host immune system is compromised or becomes weak, allowing the bacteria to successfully
overcome its immune defence, multiply and become numerous enough to cause damage to
the lungs. The infection spreads to other parts of the body or other organs [18], such as
the brain, spine, or kidneys via blood circulation. There are two main forms of TB [29, 30],
namely extra-pulmonary tuberculosis (EPTB), which refers to disease outside the lungs,
and the one attacking the lungs, referred to as pulmonary TB (PTB). The contagious
factors depend on the form of tuberculosis, but in general, only the pulmonary form of
infections is contagious.
1.2 Tuberculosis Epidemiology, Treatment and AIDS
In 1882, a German bacteriologist Robert Koch established the aetiology of TB, and stated [31]:
“If the importance of a disease for mankind is measured by the number of fatalities it causes,
then tuberculosis must be considered much more important than other most feared infec-
tious diseases, plague, cholera and the like. If one only considers the productive middle-age
groups, tuberculosis carries away one-third, and often more”. This statement still holds
word for word after more than one and a quarter centuries, with no hope so far of changing.
Indeed, according to the World Health Organization (WHO) [7, 8], tuberculosis remains a
potent infectious killer, as more than two billion people, corresponding to approximately
one-third of the world’s population, are infected with MTB, of which, one in ten develops
active tuberculosis, affecting mostly young adults in their most productive years. The
objective is to reduce the incidence of TB by half by 2015, thus hard work is required if we
are to achieve the Millennium development Goal of halting and beginning to reverse the
spread of TB as one of the world’s major diseases [32].
The first and widely used BCG (Bacille Calmette-Guérin) vaccine against TB was discov-
ered in 1906 by the two French biologists, Albert Calmette and Camille Guérin. It was
used for the first time in 1921. In addition, several compounds were introduced between
1943 and 1963 as anti-TB agents [33]. These include streptomycin (1943), p-aminosalicylic
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and rifampin (1963). This rapid succession of drugs with anti-TB activity was aimed at
accelerating the exit of TB as a public health challenge. Today, over 20 drugs against TB
are available [34] but TB is a seemingly unstoppable disease and a leading cause of human
death from infectious diseases. This clearly demonstrates the inefficiency of global TB
eradication programmes and the ineffectiveness of tuberculosis control measures and treat-
ment protocols implemented so far. The widespread emergence of drug resistant strains
constitutes a major impediment to these global TB eradication programmes, requiring the
effectiveness of coordinated strategies towards new anti-TB compounds with novel mech-
anisms of action.
One of the factors determining the virulence of MTB is its ability to switch from a replica-
tive (growth) to a non-replicative (dormancy) state [35], in response to the antimycobacte-
rial host defence mechanisms. This enables it to persist, infect, grow and survive in human
macrophages, thus making this slow growing aerobic bacterium, one of the most success-
ful human bacterial pathogens. Therefore, the properties of anti-TB agents must include
antibacterial activity, capacity to inhibit the development of resistance, and capacity to
kill these intracellular, persisting organisms. For this purpose, the initial combination of
isoniazid, rifampin, pyrazinamide, and ethambutal are used as front-line drugs [36]. Other
anti-TB agents, namely aminoglycosides/cyclic peptide such as capreomycin, viomycin,
kanamycin and amikacin, and quinolones such as moxifloxacin, levofloxin, ofloxacin and
ciprofloxacin are effective but usually used in drug resistance situations [37, 38].
Multidrug-resistant TB (MDR-TB) is a form of TB that is resistant to at least two of the
most commonly used drugs in the current four-drug or first-line therapies (isoniazed and
rifampin). Extensively drug-resistant TB (XDR-TB) occurs when there is resistance to any
fluoroquinolone, and at least one of the three injectable second-line drugs (capreomycin,
kanamycin, and amikacin) on top of MDR-TB [39]. MDR-TB treatment is difficult and
expensive [8], as much as 1400 times the cost of that of the regular treatment, and often
unaffordable by persons that are infected. The global HIV epidemic has led to an explo-
sive increase in TB incidence and contributes to increases in MDR-TB prevalence [40].
There were estimates of 500 000 new MDR-TB cases, 9.27 million incidences and 13.7 mil-
lion prevalent cases of TB in 2007 [7, 8]. Specifically, Sub-Saharan Africa has all of the
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A weakening in the immunological defence system of the host, resulting in dissemination
of the bacterial pathogen underlies the development of TB. Thus, much ground in the fight
against TB has been lost, especially in the face of the spreading of HIV/AIDS, counted
among leading infections compromising the host immune system. In Sub-Saharan Africa,
for example, approximately 75% of people with active TB are infected with HIV [8], in
which case, TB often constitutes a death sentence [42]. TB is a leading killer of people
with HIV and people living with HIV and infected with TB bacilli are 20 to 40 times more
likely to become sick with active TB than people not infected with HIV living in the same
country [43]. In 2008, 1.8 million people died from TB, including 500 000 people with HIV
corresponding to 4500 deaths a day [8]. At least one-third of the 33.2 million people living
with HIV worldwide are infected with TB and one in four people with HIV die due to
TB [43].
1.3 Overview of the MTB Genome
The biggest step towards understanding MTB virulence and its specific abilities for invasion
and division inside host macrophages and defeating the antibacterial mechanisms of these
cells, was realized with the complete elucidation and publication of the first MTB genome
sequence of H37Rv, the laboratory strain, in 1999 [9]. This has facilitated the identification
of all MTB proteins and, using computational methods through comparative and functional
genomics, the availability of these entire genomes has facilitated the identification of genes
common to all bacteria or specific to MTB, and the prediction of missing functions for
proteins, respectively. Even though the large number of uncharacterized genes limits these
genomic studies, such data has provided a basis for selecting potential drug targets from the
complete list of proteins. The genes in the MTB genome, but missing from closely related
genomes, are likely to be crucial to its pathogenicity and constitute promising candidates
for drug targets [5].
The global analysis of bacterial proteomes [44, 45] has yielded insights into functional
features of several uncharacterized proteins. This has led to the elucidation of biological
properties unique to MTB, such as its virulence, its slow growth and persistence, and
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about the pathogenicity of the tubercle bacillus. The H37Rv or laboratory strain genome
sequencing project was accomplished by the Sanger Centre (http://www.sanger.ac.uk),
in collaboration with the Pasteur Institute in Paris. One isolated clinical strain of MTB,
CDC1551, which is seen as highly transmissible and virulent for humans, was sequenced at
the institute of Genomic Research (TIGR) (http://cmr.jcvi.org/tigr-scripts/CMR/
GenomePage.cgi?org=gmt) in 2002 [10]. This offered the opportunity to compare the
two genomes and several characteristics of these genomes that were previously unknown
have been revealed [4]. In fact, such comparative analyses have provided several effective
approaches for enhancing our understanding of the molecular basis of tubercle bacillus
virulence, evolution and pathogenesis, and have made possible the analysis of intra-species
variability of this slow-growing aerobic pathogenic bacteria.
Over the years, more genome information has become available and these data are stored
in databases that are freely accessible via web interfaces (http://genolist.pasteur.fr/
Tuberculist, http://cmr.jcvi.org/tigr-scripts/CMR/shared/Genomes.cgi, etc.). This
has resulted in improved precision of functional assignments for genes and their products,
and information has become more accurate. Certain gaps in the understanding of MTB bi-
ology have been filled, and the initial annotation of the MTB laboratory strain has become
outdated. Four sequencing errors have been detected, changing its size from 4, 411, 529 to
4, 411, 532 bp [46]. We describe the MTB genome features in the following section, and
survey strain comparisons in sections 1.3.2. The three strains considered are the clinical
Oshkosh, or CDC1551 strain, ATCC25618 or H37Rv and ATCC25177 or H37Ra. The
term ‘strain’ refers to a collection of organisms closely related genetically and used in the
laboratory or with a documented pathology history.
1.3.1 Biological Organization of the Genome
The elucidation and analysis of the complete nucleotide sequences have revealed sev-
eral features of the genomes of the MTB species presented in table 1.1 extracted from
http://cmr.jcvi.org/tigr-scripts/CMR/shared/Genomes.cgi. These species of MTB
have genomes with 65.6% G+C content, approximately 4 × 106 base pairs, and 4 × 103
open reading frames (ORFs). The annotation of these 4000 genes has been classified by
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Table 1.1: Features of the MTB genome.
Features
Strains Genome size (bp) Protein Coding genes GC content(%) CDS coverage rRNA tRNA
H37Ra 4,419,977 4034 65.61% 90.84% 2 45
H37Rv 4,411,532 3948 65.61% 90.93% 5 45
CDC1551 4,403,837 4246 65.60% 92.42% 3 45
Table 1.2: Distribution of MTB proteins per functional class.
Functional Class Number of Proteins
1 Virulence, detoxification and adaptation 209
2 Lipid Metabolism 236
3 Information Pathways 232
4 Cell-wall and Cell Process 749
5 Stable RNAs -
6 Insertion Sequences and Phages 109
7 PE/PPE/PGRS Proteins 167
8 Intermediary Metabolism and Respiration 895
9 Protein of Unknown Function 17
10 Regulatory Proteins 193
11 Conserved Hypothetical Proteins 1141
strain H37Rv from http://genolist.pasteur.fr/Tuberculist).
Predicted biological roles can be assigned to 66% of the ORFs, while 17 proteins have
high sequence similarity with hypothetical proteins from other species and about 33% are
regarded as novel proteins due to no match to any known ORFs in the current databases.
The frequencies of amino acids in the whole MTB proteome are shown in figure 1.1.
Lipid Metabolism Genes
The cell envelope of MTB has been shown to contain a remarkable quantity of lipids [9],
its genome sequence has revealed several genes dedicated to their production. Indeed, as
shown in table 1.2, approximately 10% of proteins with known functional categories in
the MTB genome are devoted to this activity, with genes involved in both biosynthetic













































































































































































































































































































































































































































































































































































































































































































































































































































































































(b) Percentage of amino acids fromMethionine (M)
to Tyrosine (Y)
Figure 1.1: Distribution of amino acids in the MTB proteome.
alternative sources of carbohydrates and are involved in alternative lipid degradation from
the host vacuolar or cellular membranes, and hence contribute to energy metabolism [2].
It is essential for the survival of MTB in its host to have enzymes involved in lipid biosyn-
thesis, as its envelope, which serves as an interface with the host, needs lipids, glycolipids,
lipoglycans, and polyketides [47]. For example, a fused gene (pk1/15) encoding a pheno-
lic glycolipid is involved in a decrease in pro-inflammatory cytokine production from host
immune cells [48] and may contribute to MTB virulence [49].
The lipid components of the bacterial cell wall, such as lipoarabinomannan and sulfolipids,
have been shown to modulate the immune response and protect the organism from the host
defence system. Furthermore, MTB possesses a large number of transmembrane proteins
named MmpL located next to genes involved in lipid metabolism, and observed to act as
proton motive force-dependent efflux systems and confer high resistance to fluoroquinolones
and other antibacterial agents in the gram negative bacteria Pseudomonas aeruginosa and
Escherichia coli [2]. It has been suggested that these proteins are involved in the export of
lipids or glycolipids and may act in drug efflux and hence contribute to the extensive natural
resistance of the tubercle bacillus. It is not excluded that many other lipid metabolism
proteins have features related to virulence, for example, the bacillus contains many genes
involved in polyketide synthesis that may play a role in virulence, either as toxins or
as immune modulators functioning like the macrolactone immunosuppressor rapamycin.










Chapter 1. Introduction 10
our knowledge on the pathogenesis of MTB.
PE and PPE Protein Family
The PE and PPE protein families constitute one of the most important discoveries gained
from MTB genome sequencing projects. These two novel large and unrelated families
of acidic, glycine-rich proteins contain about 100 and 67 members [9], possessing a highly
conserved N-terminal domain of about 110 and 180 amino acid residues, respectively. These
sequences have characteristic motifs Pro-Glu at positions 8− 9 and Pro-Pro-Glu at 8− 10,
where Pro and Glu stand for Proline (P) and Glutamic (E) amino acids, respectively, and
followed by C-terminal segments that vary in sequence and length [2]. Each of these families
falls into several subfamilies based on their C-terminal domains, the PE family is divided
into three subfamilies, the most important is Polymorphic GC-Rich Sequences (PGRS),
encoding the motif AsnGlyGlyAlaGlyGlyAla. On the other hand, PPE is composed of
at least three classes of which the Major Polymorphic Tandem Repeats (MPTR) class
constitutes the biggest component, encoding Asn-X-Gly-X-Gly-Asn-X-Gly [50].
The PE and PPE proteins are generally uncharacterized and their subcellular location
is unknown except for Rv3097, which has been demonstrated to function as a lipase [9].
They form a source of antigenic variation among different strains of MTB [51] and might
interfere with immune responses by inhibiting antigen processing [52]. Some predictions of
these proteins indicate that they are expressed based on the changing micro-environments
encountered by the pathogen and play an important role in survival and multiplication of
MTB in their chosen environment, and even in mediating mycobacterium-host cell interac-
tions [53, 54, 55]. This reveals that these proteins may provide to the pathogen the ability
to switch from one metabolic path to another [56, 57] including aerobic and anaerobic
respiration, thus allowing the organism to survive within its host in different environments
ranging from high oxygen potential in the lungs to micro-aerobic/anaerobic conditions
within the tuberculous granuloma. Furthermore, these protein families have been hypoth-
esized to undergo recombination events, which increases their antigenic variability and may
have profound implications in pathogenicity and/or host adaptation [58]. The fact that
PE-PGRS proteins have been found to be exclusive to MTB complex organisms suggests
that they are responsible for survival of the organism in host macrophages [59]. In addition,
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in pathogenesis between mycobacterial species [4]. Note, the term ‘MTB complex’ refers
to a group of Mycobacterium species that cause TB in humans and other mammals [60].
ESAT-6 Protein Family
The 6-kDa Early Secretory Antigenic Target (ESAT-6) family, certain members of which
are counted among eight ORFs in the Region of Difference 1 (RD1), has been shown to
act as potent stimulators of the immune system. These members are assigned a cytolytic
role [61], which enables virulent mycobacteria to spread, thus causing greater tissue dam-
age [62]. The elucidation and annotation of the MTB genome revealed that 23 genes belong
to ESAT-6 family and these genes are distributed in 11 different regions [9]. This family
has been considered to be virulence factors as they seem to be important targets for T-cell
responses [63].
Indeed, it has been shown that the removal of RD1 encoding ESAT-6 in H37Rv attenu-
ated its virulence to that of the vaccine strain Mycobacterium bovis BCG [64]. According
to Koch’s postulate, this classifies the ESAT-6 protein family as virulence factors. This
postulate stipulates that a gene is considered to be a virulence factor if the phenotype is
found in virulent strains and its knock-out leads to attenuation, and that complementa-
tion of the mutant with the wide-type restores virulence [2]. Note that several other MTB
antigens have also been identified, including Ag85A, the phosphate-binding protein PstS,
the 36-kDA protein, and the heat-shock proteins hsp 60 and hsp 70 [65].
1.3.2 Strain Variation and Comparative Genomics
The well studied MTB strains, namely the laboratory strains H37Rv (virulent) and H37Ra
(attenuated) both share a common ancestor, strain H37, derived from the same parental
strain as the clinical strain CDC1551 [66], as described in figure 1.2.
Comparative genomics approaches have provided several insights into MTB strain evolution
and pathogenesis. These include the discovery of 16 genomic regions, known as regions of
difference (RD) 1− 16, deleted or missing in certain strains of Mycobacterium bovis BCG.
Among these, 11 RDs, namely RD1, RD4-RD7, RD9-RD13 and RD15, contain 89 proteins














Strain H37Ra Strain H37Rv
Common Ancestor of
CDC1551 and H37 strain
Figure 1.2: Evolution of three MTB strains, H37Ra, H37Rv and CDC1551, adapted
from [1].
currently used as vaccines against TB worldwide [67]. In addition, six genomic deletion
regions (RvD1-RvD6) [68] are missing in the MTB strain H37Rv relative to Mycobacterium
bovis, but only 4 are absent in H37Ra, except for RvD2 and RvD6 [1]. In fact, before the
elucidation of the genome of the MTB attenuated strain H37Ra, the molecular basis of
attenuation of virulence in this strain was unknown, and the presence of these regions could
not be used to explain this attenuation for they were present in clinical isolate (CDC1551).
Finally, about 4% of proteins with known functional categories in the MTB genome are
comprised of mobile genetic elements (insertion sequences and prophages) [46] involved in
genome plasticity of mycobacteria [69]. It has been shown that IS6110-related insertions
or deletions constitute a key player in mediating genomic rearrangements and deletions in
mycobacteria [1]. Four copies of IS6110 are found in CDC1551 compared to 16 copies in
H37Rv and 17 in H37Ra [1, 10]. As these genetic variations among MTB strains might
be a sign of selective pressure, they may play an important role in bacterial pathogenesis
and immunity [10]. Some of the genes in the PE/PPE/PE-PGRS family in the attenuated
strain are altered [1] under the influence of host immune selective pressure, likely allowing
the bacteria to adapt to its environment during infection or transmission [70]. It has been
suggested that these variations together with the lack of the expression of genes in the
RD1 region, including ESAT-6 and 10-kDa culture filtrate protein (CFP-10) [71], may be
implicated in the virulence attenuation of H37Ra [1].
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MTB genome. This enables the identification of genes and proteins which define the intrin-
sic features of MTB, thus providing a general view about MTB virulence, pathogenicity
and interaction with the host immune system. Exploiting information from comparative
genomics, several proteins have been suspected to play important roles in adhesion of the
microbial pathogen in the host system and also in its intracellular lifestyle. These include
protein members of the PE/PPE, lipid metabolism and virulence functional categories,
and with them, many proteins of the unknown functional category. These data, not only
provide a general view of the MTB genome and enhance our understanding of this organ-
ism, but also show that the use of available data and computational methods may help
us better understand the mechanisms of virulence of MTB and features that enable this
organism to adapt to or evade the host immune response.
1.4 Thesis Rationale
Despite the wide variety of anti-tuberculosis drugs, tuberculosis remains a leading cause of
human death from infectious diseases [7, 34]. The most commonly used vaccine worldwide,
BCG [67], offers some protection against TB infection in children but is considered to have
a limited protective value in adults [72]. Even for infants, it prevents the spread of MTB
within the body, but it does not prevent initial infection [73, 74]. With the emergence
of drug resistant strains of MTB, the effectiveness of current anti-tuberculosis compounds
is questionable, leading to an intensive and continuous search for new drugs with novel
therapeutic agents. One of the biggest barriers to this process is the high proportion
of proteins of unknown function in the MTB genome. Since the elucidation of the whole
genome sequence and with the help of new high throughput biology technologies, significant
successes have been recorded from comparative and functional genomics in gaining a better
understanding of its evolution and interaction with its host. However, existing information
on the microbial pathogen is still limited and incomplete. These include:
1. A significant number of hypothetical proteins in microbial genomes are labelled ‘un-
known’ and currently uncharacterized in the protein databases.
2. Incomplete information on the functional interactions between proteins due to the
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1.4.1 MTB Protein Annotation
The annotations of proteins in the MTB proteome were generally inferred from sequence
homology searches, where functions of proteins of known function are assigned to a query
protein using sequence similarity search tools, such as the Basic Local Alignment Search
Tool (BLAST) [75]. This offers an easy and effective scheme of suggesting possible functions
for proteins under consideration, but its applicability is limited. For instance, no known
sequence may be similar to the query protein in current database. Moreover, duplication
of genes after a speciation event can lead to inaccurate inference of function between
homologous sequences where a duplicate of the original gene changes its function to an
unrelated function in response to selective pressure. These annotations are not always
manually verified. Therefore, though straightforward, this approach is limited and has
thus left almost half of the proteins in the MTB proteome uncharacterized.
From the point of view of drug design, TB is currently treated with a decades-old drug
regimen, lasting at least six months [29, 76] with no guarantee of the complete sterilization
of the infection. This is, in part, due to the fact that the discovery of antibiotic drugs to
treat the disease was based on the same therapeutic targets, and this strategy has failed
to deliver a sufficient molecular diversity of drugs in order to overcome this public health
challenge. The long and complex trea ment of the disease is also leading to the development
of resistance, and the treatment of drug resistant TB is even longer and more expensive
than the regular treatment. The treatment of drug resistant strains may take between 18
and 24 months [73, 77], is often toxic and leads to negative side-effects, making patient
compliance difficult. This constitutes one of the biggest limitations to any attempts in
using derivatives of the existing anti-tuberculosis drugs for the development of new ones.
Though attractive and economical, since the identification of novel drug targets for diseases
and development of new drugs are always expensive and time-consuming, this strategy is
limited for this specific organism.
In addition to hampering the search for new drug targets, progress towards the advance-
ment of research on MTB and enhancement of our understanding of its virulence and
pathogenicity is weakened by the high proportion of proteins of unknown function in its
genome. Therefore, there is an urgent need for predicted functional annotations for this
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researchers to apply these data to the search for new drug targets and thus for the devel-
opment of novel and effective drugs with new biological mechanisms of action against drug
susceptible and drug-resistant strains, reliably administered with a shorter regimen.
1.4.2 Existing MTB Functional Networks
Most processes in a living cell are accomplished through protein-protein interaction net-
works, therefore these play a central role in most activities involving the structure and
function of the cell. These include signal transduction, protein folding, cell cycle control,
DNA replication and transport [78]. The most commonly used integrated functional net-
works for many other organisms [34, 79, 80], are obtained from the Search Tool for the
Retrieval of Interacting Genes/Proteins (STRING) database [81, 82]. In this functional
network, edges are protein functional interaction links. These links are based on different
evidence types, including direct or physical protein-protein interactions and many other
types of possible functional connections. The STRING scoring system for protein or gene
interactions is benchmarked by the Kyoto Encyclopedia for Genes and Genomes (KEGG)
database [83] in which only 1028 out of more than 4 × 103 encoded proteins in the MTB
proteome have a known pathway, representing about 25%. This constitutes the biggest
limitation for scoring newly discovered interactions between genes and/or proteins, specif-
ically for MTB which is not a model organism. In addition, the experimental data in the
STRING database for this particular organism is very limited.
As an illustration, when dealing with microarray data, the STRING database retrieves its
co-expression interactions from ArrayProspector (www.bork.embl.de/ArrayProspector) [84].
However, a large amount of microarray data for MTB are being generated and are publicly
available in other resources, and these may increase the accuracy and precision of STRING
data. In the case of homology data, the STRING scoring system relies on the E − value
obtained from sequence similarity searches. However, there are also protein signature
databases such as InterPro [85], which is an integrated database for protein families and
domains (http://www.ebi.ac.uk/interpro) [86], and can be used to increase the reliabil-
ity and coverage of these homology data. Therefore, there is a need for an effective scoring
system that does not rely on KEGG in order to fill gaps found in homology and microarray
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which constitutes the dynamic closure of the currently used MTB functional networks.
This means that this MTB network can easily be reconstructed the instant the biological
data for the organism are updated. We need to take advantage of different available data
for MTB and integrate these, combining updated information from multiple interaction
data sources into one unified network, with higher confidence and increased coverage.
This dynamic closure MTB functional network will enable researchers to better understand
the biological processes that proteins are involved in. The interplay between proteins as well
as each protein’s role or function can be studied through the stability of the system under
unchanging environmental conditions and the robustness of the system under changing
environmental conditions or stressful perturbations.
1.5 Project Outline
The quantity of biological data is increasing exponentially resulting from worldwide DNA
sequencing efforts and high-throughput biology technologies. We assume that these data
can be categorized into two groups, namely primary data, such as genomic sequences,
and secondary, or functional data. Building upon this assumption, this thesis revisits the
problem of existing functional protein-protein networks to propose:
• New scoring systems for functional relationships extracted from sequence and mi-
croarray data.
• Data integration strategies which can be deployed for extensive integration of biolog-
ical data into a single network with a specific focus here on the MTB genome.
The resulting network provides a mechanism for protein function prediction and gaining a
better understanding of the biological organization of this organism. The main objectives
of the project are thus two-fold:
1. Construction of the MTB functional network and use for protein func-
tion prediction. We have carried out large-scale integration of STRING data together
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data-driven scoring system, yielding a dynamic closure of the existing protein-protein func-
tional network, and enabling its update at any instant data are updated. This network is
used to predict, where possible, functions of uncharacterized proteins on the basis of the
Gene Ontology (GO) [87] functional annotations of their neighbours using the state-of-art
similarity metric derived from a GO-universal metric. The existing guilt-by-association
approaches require the exact match of terms used to characterize proteins when predict-
ing functions of unknown proteins. This is not convenient when dealing with terms in
the GO Directed Acyclic Graph (DAG), in which terms can be similar at a certain level
without being identical. Therefore, we developed the GO-universal metric to overcome
this limitation. We then use GO terms to predict, where possible, the functions of pro-
teins labelled ‘uncharacterized’ by observing the pattern of their neighbours in the MTB
functional network. In order to achieve better trade-off between improvement of quality,
genomic coverage and scalability, the “Guilt-by-Association” approach has been extended
to annotate these proteins by observing the key principles driving the functions imposed
on a protein by its neighbours, referred to as ’traces’ of underlying biological mechanisms.
2. Structure analysis of the network. The protein-protein functional network ap-
proach is being used more and more in the post-genomic era for a better understanding
of cell functioning and organism development [34, 79]. We have conducted extensive com-
putational analyses to dissect the MTB functional network produced in order to reveal
the biological organization of the organism and to infer the role of the organism’s proteins
on the basis of the network’s topological properties. This improves our understanding of
protein functions and interactions and facilitates the identification of potentially important
proteins that may be suitable drug targets, thus providing the opportunity to expand the
range of potential drug targets and to move towards optimal target-based strategies.
These objectives are depicted in figure 1.3 which describes the approach used in the project
from data integration to the main analyses conducted. In addition, data produced have
been stored in a MySQL database and made accessible via a web interface at http://
lab12.cbio.uct.ac.za/tbannotations_v2/.
The rest of this thesis is organized as follows: Chapter 2 addresses issues related to the
current scoring approaches used for homology and microarray data, and introduces novel

















































Functional Network Function Prediction of
uncharacterized proteins
Structure Analysis
Figure 1.3: Schematic representation of MTB genome analysis.
fident homology network, and a partial least squares approach for microarray data, pro-
ducing an MTB co-expression network with the exact complexity of the model, i.e., with
the model that avoids risks of “over-fitting” or “under-fitting” data under consideration by
controlling model parameters. In chapter 3, we infer the MTB functional network by com-
bining heterogeneous data for protein-protein functional interactions and defining a unified
weighting scheme in order to normalize or standardize these different schemes. In chap-
ter 4, we use the network produced to perform functional analysis of the MTB proteome
and predict, where possible, functions of uncharacterized proteins. The work presented in
chapter 5 consists of using the functional network induced for identification and further
analysis of potentially important genes on the basis of the network structure. We conclude











Integrative Scoring System for
Sequence and Microarray Data
This project aims to build a functional association network for proteins in MTB to gain a
better understanding of its biology. As mentioned above, existing resources like STRING
have limitations in some of their data or methods, and here we address these for sequence
homology and microarray information by incorporating additional data and developing
new scoring methods for converting the data into pair-wise protein functional associations.
The abundance of diverse biological data from various sources constitutes a rich resource of
genome knowledge from which functional association datasets can be derived. For example,
from genome or protein sequences we can perform sequence similarity searches using the
Basic Local Alignment Search Tool (BLAST) [75] in order to infer homology-based func-
tional associations. Using data from protein domain and family databases, the inference
of functional associations can be carried out based on the fact that two proteins sharing
common domains or belonging to the same family are more likely to be functionally linked.
These functional associations tend to be in Boolean or binary format, i.e., either two genes
or proteins are functionally linked, in which case the score is 1, or they are not and the
score is 0. Such a scoring scheme for measuring functional links from different data types
is not consistent or effective, since it does not take into account certain parameters, such
as uncertainty of data, or noise inherent in the experiments used to derive these data.
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ments [88, 89], the uncertainty of data and noise inherent in each experiment must be
efficiently managed by systematically weighing or scoring functional associations [81] de-
rived from them. This is referred to as a reliability or confidence score of functional as-
sociations for the computational approach used for the prediction. These scoring schemes
must be data source and technology dependent. This means that a given scoring scheme
should normally vary according to the data sources and be designed on the basis of knowl-
edge about the technology used. Furthermore, the effectiveness of a scoring scheme for
functional associations is critical for the quality of post-analyses of the network, including
functional and structural analysis, and will influence the predictions performed on the basis
of these networks. Therefore, failure in setting up an appropriate scheme may negatively
impact on the prediction analyses performed on the basis of these networks. This chap-
ter revisits the existing scoring schemes of functional associations for data from protein
domain and family databases, sequence similarity and microarray experiments to propose
new efficient and effective schemes.
2.1 Scoring Inferences from Sequence Data
Scoring functional relationships from sequence data, which include protein family and
shared domain, as well as sequence similarity data, has been widely addressed by the
Bioinformatics community. However, the approaches used so far in the literature are
limited to finding the similarity scores between proteins. In the case of protein family and
domain data, this similarity score represents the number of common signatures shared by
proteins (a protein signature is a model describing protein domains, families or sites). Two
examples of such a scheme are given below.
Scheme 1: Scoring Function of Pfam Domain Sharing [89].
The scoring function Spfam of Pfam domain sharing is simply the number of common
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Scheme 2: Scoring Function based on Protein Signature Profiling [90].
The similarity score between a pair of proteins (Pı,P) is computed using a binary similarity









where n is the number of signatures contained in proteins of a genome of interest and
Pℓ = [Sℓ1, Sℓ2, . . . , Sℓn] the signature profile of protein Pℓ, with Sℓk = 1 if the signature Sk
exists in protein Pℓ and Sℓk = 0 otherwise.
For sequence similarity data, the scoring schemes found so far in the literature all rely on
the use of E − values obtained from sequence similarity tools [34, 89, 91, 92, 93], such
as BLAST. Very often, a negative log E − value between each protein pair is used and
some of them incorporate metabolic pathway information from Kyoto Encyclopedia from
Genes and Genomes (KEGG) for validating or justifying these scores. The problem with
these scoring schemes is that initially there is no single fixed E − value describing where
homology ends and non homology begins. This constitutes an impediment to these scoring
schemes beyond the fact that they may obviously lead to the singularities caused by the
log of zeros.
Thus, these schemes are not adequately equipped to capture all the parameters related to
the data under consideration and technology used to derive them, and/or to satisfy numer-
ical computational requirements. In order to overcome these shortcomings, we introduce
information-theoretic based measures to score protein-protein relationships in functional
interaction networks predicted from sequence data. In these measures, the mutual infor-
mation of the evolutionary history of protein pairs is corrected by the maximum entropy,
measuring how each protein sequence is able to predict the other and thus translating the
amount of information shared between proteins into the score of their functional relation-
ships. This allows us to produce a protein-protein functional network from homology data
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2.1.1 Scoring Scheme For Protein Family and Domain Data
Consider two proteins denoted Pı and P sharing signatures or entries S1, . . . ,SM . We
define the similarity score ηı of proteins Pı and P as the sum of the minimum number of
occurrences of these signatures in proteins Pı and P, i.e.,




where skℓ is the number of occurrences of signature Sk in the protein Pℓ.
Broadly speaking, the reliability or confidence score increases with the confidence-level
of data, which depends on the data source and decreased with the uncertainty-level of
data linked to the dispersion measure σ. As we are dealing with data from experiments
containing a certain level of uncertainty, which propagates into the data, it is natural to use
the normal distribution, as these data can be summarized in terms of mean and standard
deviation. In fact, in this case this distribution constitutes an attractive approximation as
it maximizes information entropy in the data. Thus, we set the confidence-level δ of the
similarity score η as




















and α the control parameter, with α ≥ 1/2, strengthening the impact of the confidence-
level through similarity score η for the data under consideration. And σ the standard
















(xk − x̄)2 (2.6)
where N is the number of signatures found in the rectified dataset, xk the number of
times the signature Sk was observed, and x̄ =
∑N
k=1 xk/N the mean or average of the set.
The training dataset D consists of all pairs (Sk, xk), where xk is the number of times the
signature Sk was observed. In order to get rid of observations that lie at abnormal distances
from the data, referred to as outliers, it is recommended to use the rectified dataset DS,




(Sk, xk) ∈ D : Q1 − 1.5 (IQR) ≤ xk ≤ Q3 + 1.5 (IQR)
}
with Q1 and Q3 are respectively 1st (lower) and 3rd (upper) quartile, and IQR = Q3−Q1
the interquartile range.
Given the confidence-level δ of the similarity score η defined in equation (2.4), the un-
certainty measure related to the outcome η resulting from the data is obtained from the
binary entropy function, given by
H2 (δ) = −δ log2 (δ)− (1− δ) log2 (1− δ) (2.7)
In fact, the uncertainty measure function H2 (δ) is defined in the interval [0, 1], with
H2 (0) = 0 = H2 (1) since lim
ǫ→0+
ǫ log2 (ǫ) = 0, and also lim
ǫ→1−
(1− ǫ) log2 (1− ǫ) = 0.
Finally, we set up the capacity of inferring the functional relationship score between two
proteins belonging to the same family or sharing common signatures as
Γ (δ) = 1−H2 (δ) (2.8)
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Note that for η sufficiently large, δ converges to 1. Therefore, the uncertainty measure
H2 (δ) converges to 0, leading to the maximum capacity of inferring the functional re-
lationship of 1. This means that the reliability of a functional relationship between two
proteins is given by
R = Γ (δ) /bit (2.10)
To illustrate the dependency of this new measure on the data under consideration and the
technology used to produce them, we plot the variation of confidence level δ, uncertainty
H2 and capacity Γ in terms of common domains η between proteins, for different values of
α, which keeps track of the technology used to produce data and σ controlling the impact
of data under consideration, respectively. These are user-tunable parameters and results
are shown in figure 2.1.
These results show that the confidence level δ increases as the number of common signatures
between the two proteins increases, and that for a higher value of α, indicating the efficiency
level of the technology used to derive data, the confidence level δ is higher, and so is the
reliability or confidence score, due to the fact that in this case the uncertainty component is
smaller. Similarly, the impact of data obtained from each technology is taken into account
through σ. Interestingly, this confidence score formula accommodates the case where no
common pattern is found between two proteins in the training dataset, in which case, the
confidence score or reliability of a functional relationship is 0. In addition, this scoring
scheme takes into account a false positive assignment of any of the common patterns by
narrowing down the confidence score of proteins containing only one common signature,
depending on the measure of dispersion σ which can provide a hint on the nature of the
data under consideration. Indeed, the measure of dispersion σ impacts on the confidence
score in the sense that if data is far away from the average, in which case σ is high,
the uncertainty component might be large and significant while calculating the confidence
score, thus yielding a lower confidence score. Thus, with knowledge of the data source, the
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(a) Confidence level variation for α = 1. (b) Confidence level variation for σ = 2.38.
(c) Variation of uncertainty in terms of σ. (d) Variation of capacity in terms of σ.
Figure 2.1: Uncertainty component and reliability variations in terms of tunable parameters
α and σ.
the impact of the uncertainty component.
We compare this new approach to the approach based on protein signature profiling given
in equation 2.2, and results are shown in figure 2.2. As the approach based on protein
signature profiling may produce several link scores for the same number of shared domains,
we have considered the maximum of scores when over-estimating, their minimum when
under-estimating and their average. These results indicate that our approach provides a
better trade-off between over-estimating and averaging all scores for a given number of
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Figure 2.2: Variation in scores for the Protein Signature Profiling (SFSP) based approach
and for our approach.
2.1.2 Scoring Inferences from Sequence Similarity Data
For a given set of pair-wise homologous sequences, Bastian et al. [94, 95] showed that
their biological evolution can be formalized by the evolution of the amount of information
they share, which is measured by the mutual information in the sense of Hartley [96, 97],
estimating the information they share due to their common origin and parallel evolution
under similar selective pressure. Moreover, this mutual information is proportional to the
bit score computed with standard methods in sequence comparisons.
Let S (s1, s2) be the bit score alignment of homologous sequences s1 and s2 set with its
standard units, and M (s1, s2) be mutual information between these two sequences, then
we have
S (s1, s2) = ϑ×M (s1, s2) (2.11)
where ϑ is a constant defining the unity, which depends on the statistical parameter scaleK
for the search size [98], and derived from a scoring matrix and the amino acid composition
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they have the same scale for the search size. However, the mutual information M (s1, s2)
between two sequences s1 and s2 satisfies M (s1, s2) = M (s2, s1) and M (s1, s2) ≥ 0 [100].
Equation (2.11) shows that the mutual information M (s1, s2) increases with the bit score
S (s1, s2) , which measures the average information available per position to distinguish
the alignment from chance, calculated as the relative entropy of target and background
distributions [101]












where qı, the “target” residue substitution frequency, is the probability of finding a residue
ı aligned with a residue  after a certain amount of evolution given that they have both
evolved from a common ancestor who had a residue k at that position. In addition, pı is
the probability of occurrence of a residue ı in a collection of sequences, i.e., the probability
that a residue ı would align by chance based solely on its frequency in a sequence.
Thus, we define the reliability or confidence score R (s1, s2) of the functional relationship
between two protein sequences s1 and s2 as the normalized mutual information calculated
as
R (s1, s2) =
M (s1, s2)
max {H (s1) ,H (s2)}
(2.13)
measuring how the protein sequence s1 is able to predict the protein sequence s2, and where
H (s) is the relative entropy obtained by aligning protein sequence s by itself. Indeed, the
increase of mutual information with relative entropy yields bias, and this bias is corrected
by dividing the mutual information by the maximum entropy of the sequence pair.
Using equation (2.11), the mutual information M (s1, s2) can be computed as follows
M (s1, s2) =
S (s1, s2) + S (s2, s1)
ϑ+ ϑ′
(2.14)
where ϑ and ϑ′ are constants defining unity for S (s1, s2) and S (s2, s1) respectively. For a
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H (s) = 2× S (s, s)
ϑ+ ϑ′
(2.15)
Finally, R (s1, s2) is independent of constants defining unity for S (s1, s2) and S (s2, s1),
and is calculated as
R (s1, s2) =
S (s1, s2) + S (s2, s1)
2×max {S (s1, s1) , S (s2, s2)}
(2.16)
It is obvious that this scoring scheme relies only on the two protein sequences for which
the confidence score is being computed. Two protein sequences whose mutual information
of their evolutionary history embedded in their similarity score is 0, indicates that the two
sequences are not similar and so, their confidence score is also 0. Thus, this scoring scheme
accommodates the case where no similarity is found between two protein sequences and
the error due to the arbitrary growth of the mutual information between two protein pairs
is corrected by the maximum entropy induced.
2.1.3 MTB Functional Networks Derived from Sequence Data
We apply these scoring schemes to the whole MTB strain CDC1551 proteome to produce
functional links between proteins from sequence data, including pair-wise links from se-
quence similarity and protein family data derived from the InterPro database. Sequence
similarity searches were carried out using BLASTP under a BLOSUM62 matrix based
on the premise that if the E − value is less than 0.01, the hit is similar to the query
sequence and is likely to be evolutionarily related, and thus is generally suggestive of
homology [102]. Sequences in Fasta format and InterPro data for the organism were
downloaded from the Integr8 project of the European Bioinformatics Institute (EBI) at
http://www.ebi.ac.uk/integr8.
The general behaviour of the link confidence scores (score of functional links between
protein pairs) induced from sequence datasets has been analyzed and results are shown in
table 2.1, in terms of number and frequency of functional links in a given bin S : x, where
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Sequence Similarity Protein Family and Domain
Confidence Bins Our Approach STRING scheme Our Approach SFSP-Under SFSP-Aver SFSP-Over
Low S : 01 4321 0 0 33240 0 0
S : 02 3001 0 0 4365 0 0
S : 03 1206 0 0 814 0 0
S : 04 606 44 20915 172 27494 0
Medium S : 05 424 263 0 6 6 6
S : 06 215 140 0 41 5746 0
S : 07 96 99 0 45 1394 0
High S : 08 31 57 7847 0 3906 0
S : 09 21 58 0 18 155 45
S : 10 25 52 9945 6 6 38656
Medium-High Total: 812 669 17792 116 11213 38707
Overall Total : 9946 713 38707 38707 38707 38707
Table 2.1: MTB strain CDC1551 functional links derived from sequence data using our
approach, STRING homology scheme for sequence similarity, and using the SFSP approach
for protein family and domain sharing. Number of Interactions per Source and Link Score
shown separately by bin.
These results indicate that the link confidence scores from protein family data are either
low (< 0.4) or high (> 0.7). This is due to the calibration control parameter applied
to data from the InterPro database, which is α = 1 with penalty parameter ǫ = 0.45,
producing either low or high confidence according to the fact that two proteins shared only
one domain or more than one domain, respectively. Moreover, in most cases, detection
of functional links from sequence similarity matches that of protein family data but at
different confidence levels.
2.1.4 Evaluation and Comparison with STRING Scheme
We evaluated the statistical significance and biological relevance of the functional in-
teractions inferred using our scoring approach in terms of functional classification co-
herence. The functional classes for each MTB protein were extracted from Tuberculist
(http://genolist.pasteur.fr/Tuberculist), and to determine functional coherence,
an interaction between two proteins is said to be significant or correct if these proteins
belong to the same functional class. We compared our approach to the STRING homology
scoring scheme. The STRING scheme classifies its functional link confidence scores into
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than 0.4, between 0.4 and 0.7, and greater than 0.7, respectively [81]. The comparison was
performed in terms of functional classification accuracy for links with a medium confidence
level and upwards (link score greater than 0.4). The number of associations in the MTB
functional network are shown separately in table 2.1 for each approach and confidence
ranging from low to high. The evaluation was done using a sub-network generated by each
protein in the functional network, consisting of functional interactions between a protein
under consideration and its direct neighbours, referred to as a P-subgraph. The proteins
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(b) Our Approach and SFSP Evaluation
Figure 2.3: Significance of Functional Interactions Derived using Our Approach, the
STRING scheme and SFSP approach. At each significance level α in these graphs, we
counted all relevant predicted associations for the two approaches and computed the per-
centage. Each α corresponds to the number of associations with p-value β and α < β ≤ α,
where α is the significance level just before α in the plot.
Statistical Significance of Functional Interactions Derived
To assess functional category coherence of functional interactions derived from a random
model, we compute the P-value for each P-subgraph defined as the probability that the
P-subgraph under consideration occurs by chance or is comprised of randomly drawn inter-
actions. The hypergeometric distribution, which yields the probability of observing at least
ℓ interactions between proteins from a given P-subgraph of size S by chance among I in-
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Line: TP = FP
(a) Our Approach and STRING Scheme



















Line: TP = FP
(b) Our Approach and SFSP
Figure 2.4: Modified ROC curves for functional interactions. Number of incorrect func-
tional interactions (false positives) versus number of correct functional interactions (true
positives) in the MTB strain CDC1551 functional networks produced by our approach
and the STRING homology network for sequence similarity, and SFSP scheme for protein
family and domain.
distribution, is used to model the P-value [91] given by














where L is the size of the functional network, i.e., the number of functional links in the
network, with all the proteins in the unknown class removed.
We assessed functional category coherence of functional interactions derived using our ap-
proach and STRING homology data for sequence similarity, as well as those inferred using
our scheme for protein family and domain, and those obtained using SFSP-Mean and
SFSP-Max estimation. Results displayed in figures 2.3(a) and 2.3(b) show that the func-
tional interactions induced have a very low probability of occurring by chance. Note that
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in the functional network consists of randomly grouped proteins. These figures show that
using a significance level of 0.05 as the optimal threshold, more P-subgraphs derived using
our approach are statistically significant than those obtained from the STRING homol-
ogy scoring and provides roughly equal statistically significant percentage of P-subgraphs
with SFSP-Mean and SFSP-Max schemes. A total of 205 out of 378, representing 54.2%
of P-subgraphs in our network are significant compared to 213 out of 485 representing
43.9% of P-subgraphs for the STRING scoring system for sequence similarity. For SFSP
scheme for protein family and domain, A total of 1078 out of 1515 representing 71.2% of
P-subgraphs in our network are significant compared to 901 out of 1261 representing 71.5%
of P-subgraphs for SFSP-Mean and to 1517 out of 2024 representing 75% for SFSP-Max.
Effectiveness of the Novel Scoring Scheme
To evaluate the classification power of the new scoring scheme, we used the modified Re-
ceiver Operator Characteristic (ROC) curve analysis that measures the number of true
positive (TP) predictions (number of functional interactions correctly identified) against
the number of false positive (FP) (number of functional interactions incorrectly identi-
fied) [103], in which case the area under the ROC curve (AUC) is used as a measure of
discriminative power. The larger the upper AUC value (the portion between the curve and
the line TP = FP), the more powerful the scheme is.
For a given number of P-subgraphs ranging from 5 to 485, we randomly generated 1000
independent samples and compute the average number of correct and incorrect predicted
interactions expected to be normally distributed from the central limit theorem. Thus,
we perform modified ROC analyses for the two scoring approaches, and results are shown
in figure 2.4(a) for sequence similarity. These results indicate that our approach outper-
forms the STRING scheme, respectively, with an average of 95.9% and 4.1% of functional
interactions correctly and incorrectly identified out of 378 P-subgraphs, compared to the
STRING scheme, which provides an average of 89.3% and 10.7% of functional interactions
correctly and incorrectly identified, respectively, out of 485 P-subgraphs. This shows not
only that it is not sufficient to ensure high quality matches [104] by just applying a reason-
ably strict cut-off score when using the Smith-Waterman algorithm, but also this practice
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comparably to the SFSP-Max and SFSP-Mean schemes, and provides a better trade-off
between over-estimating and averaging scores for SFSP schemes in terms of precision and
coverage. Our approach provides an average of 79% and 21% of functional interactions
correctly and incorrectly, respectively, identified out of 1515 P-subgraphs. SFSP-Mean
yields an average of 80.5% and 19.5% of functional interactions correctly and incorrectly
identified, respectively, out of 1261 P-subgraphs while SFSP-Max produces an average of
73.3% and 26.7% of functional interactions correctly and incorrectly identified, respectively,
out of 2024 P-subgraphs. Apart from the general limitation common to scoring schemes
inferred from signature profiling based approaches, SFSP-Max produces a poor precision.
This poor performance is due to the fact that when over-estimating it includes all false
positives and our approach corrects this, providing an improved precision and coverage.
2.2 Scoring Inferences from Microarray Data
On the basis of the central dogma of biology [105, 106], large scale gene expression mapping
finds its origin from the fact that the information on gene expression determines the infor-
mation on the functional state of an organism. Technologies such as microarrays have been
developed to measure the expression level of thousands of genes simultaneously. In fact,
microarray technology constitutes one of the most promising tools today to researchers in
life science [107], providing an innovative platform for biologists to investigate the dynamic
nature of gene dependencies [108]. As a consequence, computational tools are needed in
order to extract useful knowledge from such large scale data and to infer relationships
between genes from their expression patterns. These vast amounts of data generated at all
levels of biological organization can help us to decipher the co-expression network of the
genome under consideration. The challenge then lies in tracing the connections and re-
vealing them, i.e., inferring and scoring important gene-gene functional relationships from
these data.
Based on the nature of microarray data, usually with a large number of genes and relatively
small number of measurements, Principal Component Analysis (PCA) and Partial Least-
Squares (PLS) Regression are two methods which can be used to process these data.
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information extraction and exploration of relationships between genes from their expression
patterns. A traditional approach that is very often used, consists of clustering genes using
Pearson or Spearman correlation coefficients as distance measures [108] and, in most cases,
gene-gene association is characterized by just the correlation coefficient between these
genes [111]. However, it is not known how correlated the expression profiles should be in
order to infer a relationship between genes, and even knowing the threshold correlation can
never provide the evidence of a causal relationship, and more importantly this correlation
threshold may only tell us that there exists dependencies between genes without predicting
one gene from another. Thus, we decided to make use of a random partial least squares (r-
PLS) approach to characterize relationships between genes from microarray data. Each
gene is first regressed on all other genes through the r-PLS approach and coefficients are
used as a measure (score) of potential relationships between genes, which are later subjected
to a statistical test for significance in order to identify outliers. Unlike other approaches
in which the complexity of the model is a user-tunable parameter, this approach provides
the exact complexity of the model.
Several approaches have been designed for inferring genome-wide co-expression networks of
organisms given expression patterns of their genes derived from microarray data, in order
to understand normal cell physiology and pathological phenotypes [112]. The description
of these approaches can be found in the work published by Markowetz and Spang [113].
Among these approaches, we have encountered partial correlation coefficient methods [114,
115], in which, the partial correlation coefficients are used as a measure of interaction
strengths between genes. There are also information-theoretic-based approaches such as
ARACNe [112, 116], and Bayesian models such as BANJO [117]. Pihur and colleagues [110]
compared these approaches to PLS-based methods, which have been shown to outperform
all these approaches and to be a powerful screening tool for discovering interactions among
genes from microarray data.
The PLS regression approach has been proven to be a highly efficient statistical regression
technique [118, 119], very often the best choice among many statistical methods for linear
models with a multicolinearity problem [120], and especially in the presence of noisy data
with a limited number of observations [121, 122]. This makes the PLS approach very
attractive for the analysis of microarray data which comes with the curse of dimensionality
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(factors or latent vectors) from predictive or independent, or cause or input variable X , that
best predict response or target, or dependent or effect, or output variable Y , by successively
extracting factors from both X and Y which explain, as much as possible, the covariance
between X and Y [123]. The PLS regression is quite similar to the PCA approach, the key
idea driving these two approaches is the dimension reduction of the original data set by
constructing a new set of factors spanning the original data set, without losing essential
information. The difference is that the PCA approach decomposes only the predictive
variable X in order to obtain factors which better explain X , i.e., which explain, as much
as possible, the variance of X and no importance is given to how each predictive variable X
may be related to the response variable Y [124]. So PLS performs one more step allowing
cause and effect relationships to be modeled via regression.
Due to the nature of microarray data, in which noise cannot efficiently be controlled, pa-
rameterizing the complexity of the model will very often lead to outliers by losing useful
information when over- or under-estimating the model. we are using the random par-
tial least squares (r-PLS) approach to produce a MTB co-expression network with exact
complexity of the model. Unlike standard PLS in which the number of components or
factors is a user-tunable parameter and very often randomly chosen, the r-PLS approach
provides a way of optimally finding the number of components needed to represent data
under consideration. In this section, we describe briefly the general underlying model of
multivariate Partial Least Squares (PLS), and the PLS algorithm in its classical form based
on the non-linear iterative partial least squares (NIPALS) algorithm. Thereafter, we set
up the statistical test for the significance of the scores (regression coefficients) found. Fi-
nally, the r-PLS approach is used to generate the co-expression network of the organism
under study from the microarray data extracted from the NCBI GEO [125] and Stanford
Microarray [126] databases.
2.2.1 Description of PLS Method and Algorithm
Given respectively data matrices of predictive variables X and target variables Y from n
observations with k different predictive and m different target variables, the PLS approach
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X = TPT + E and Y = UQT + F (2.18)
with TTT = I = UTU and where T and U, P and Q, and E and F are respectively n× r
scores, k × r and m× r loadings, and n× k and n×m residuals of X and Y as described







































































Figure 2.5: Description of predictive and target variable decompositions.
PLS Method
The PLS regression is then a stepwise procedure, where at each step the scores t and u are
extracted from X and Y respectively, reducing the dimension of the predictor and target
variables by projecting them to the directions ω and q respectively called input and output
weight, that maximize the covariance between input score t and output score u. This is
the PLS approach based on the non-linear iterative partial least squares (NIPALS), which
consists of finding, at each step, the pair of weights ω and q that solves the following
non-linear problem [127].
max tTu
subject to ωTω = 1 = qT q
(2.19)
and the scores t and u are given by
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So, the decomposition of both predictor and target matrices is done by introducing an
input weight ω with the corresponding loading vector p.
NIPALS-PLS Algorithm
Based on the PLS regression principle in finding a pair of weights ω and q, we highlight
the PLS algorithm as described by Höskuldsson [127] and used by Rosipal et al. [128] and
Abdi [123]. At the beginning the matrices denoted E = E(1) and F = F(1) are respectively
set to the column standardized (centered to have mean 0 and standard deviation 1) data
matrices of X and Y , i.e., E(1) and F(1) are column Z-score transformations of X and Y .
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Figure 2.6: Graphical view of the auto-scaling effect.
The search for factors or components containing the most information as depicted by







(a) Plotting the Observations (b) Effect of Mean−centering and Factors
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Figure 2.7(a) shows that x1 and x2 do not properly describe the information and (b)
emphasizes the fact that the first component PC1 contains the most important information.
To obtain these components, we have to find the scores t and u. At each extraction process
of these scores, the vector u is initialized with the first column of F and the following steps
are then repeated until convergence:
1. Scale u to be of a unit length, i.e., ‖u‖2 = uTu = 1.
2. ω = ETu and scale ω to be of unit length.
3. t = Eω and scale t to be of unit length.
4. q = FT t and and scale q to be of unit length.
5. u = Fq.
Thereafter, the loading vector p for X and the value of b used to predict Y from t are
computed as p = ET t and b = 〈t, u〉 = tTu. Assuming that ℓ vectors have been extracted,
to move to the next extraction process ℓ + 1, the deflation process is done by subtracting
the effect of t from both E and F, and repeating the above process with updated matrices
E and F set to the residual matrices given by
E(ℓ+1) = E(ℓ) − t(ℓ)pT(ℓ) and F(ℓ+1) = F(ℓ) − b(ℓ)t(ℓ)qT(ℓ) (2.21)
where t(ℓ), p(ℓ), q(ℓ) and b(ℓ) are parameters obtained at step ℓ. The residual matrix E
becomes null when all the factors have been extracted.
2.2.2 Computational Approach to NIPALS-PLS Algorithm
As observed, the PLS algorithm is built on the properties of the non-linear iterative partial
least-squares (NIPALS) algorithm by finding one factor at time. For this purpose, vectors
p, q, t, and u are saved as columns in the corresponding matrices at each iteration, and
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By sequentially substituting the rightmost variable from step 2 of the NIPALS-PLS algo-
rithm, we can see that the input weight ω is proportional to ETFFTEω and similarly the
output weight q is proportional to FTEETFq. We have
ETFFTEω = λω and FTEETFq = µq (2.22)
for certain λ, µ ∈ R.
This means that the solution to the PLS problem is to obtain at ω and q, the largest





it follows that ω and q are respectively the first right and left singular
vector of the matrix
S = ETF (2.23)
Thus, computationally ω and q are obtained by using Singular Value Decomposition (SV D)
of the matrix S as first right and left singular vectors respectively. Then, t, p and u are
computed as
t = Eω, p = ET t and u = Fq (2.24)
and b is the inner product of t and u, i.e., b = 〈t, u〉 = tTu.
2.2.3 Co-expression Network and Outlier Detection
The PLS method is used to draw meaningful inferences for revealing the regulatory in-
teractions of genes from gene expression data. Interacting genes are more likely to share
common genetic control processes and may therefore be functionally related or may at least
belong to the same pathway. These interactions are embedded in a co-expression network
in which all of these interactions can be indirect through one or more intermediates. A
direct link between two genes ı and  means either one of them is regulating another or the
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link, considered to be the interaction strength between these two genes, is the significant
magnitude of the regression coefficient obtained.
PLS Regression Coefficient
With the PLS method as a regression model, the computed factors or latent components
are used instead of the original variables. Thus, once T, P, Q and U are constructed, the
target or response matrix Y is estimated as the fitted response Ŷ with the inner relation
U = TB linking both predictor matrix X and response matrix Y . This fitted response
matrix may be written
Ŷ = TBQT = XB̂PLS (2.25)






with P T+ the Moore-Penrose pseudo-inverse of P T .
Notice that for starting the NIPALS-PLS algorithm, predictor and response variables are
standardized. The non-standardized prediction model is given by
Ŷ = B̂0 + X B̂PLS (2.27)
where B̂0 = µY + c
T






· BPLS, with µZ , σZ and σ−Z respectively
column vectors whose components are mean, standard deviation and standard deviation
inverse of each variable in data matrix Z, and the operator “ · ” defines the multiplication




where ∆X is the
matrix whose rows are equal to (µX · σ−X )T .
An attractive aspect of the PLS approach is the dimension reduction, the transforma-
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space [120, 130, 131, 132]. This compression is done in such a way that the loss of significant
information is minimized. The issue here is to determine the optimal number of factors
which provide a well fitting model with significant predictive power. Therefore, strict test-
ing of the predictive significance of each factor when constructing them is necessary, as well
as stopping as soon as factors start to become non-significant. To deal with this problem, a
cross-validation technique has been proposed and extensively used [123, 133, 134, 135, 136]
to determine the correct complexity of a model.
Determination of the Number of Factors
In order to successfully use the PLS method, one has to optimally fix the number of factors
to be extracted in the dimension reduction process. The Cross-Validation (CV) technique
has been proven to be a practical and reliable way of testing the predictive significance
of the PLS model. Specifically, leave-one-out cross-validation has been suggested as a
standard technique of determining the optimal number of factors [123, 135, 136].
Assuming that the number of factors is given, referred to as a fixed model, the goodness of
fit or the quality of the PLS regression model is measured by the prediction error, referred

















is the matricial Frobenius norm and here
tr( ) is the trace function. It follows that the smaller the value of RESS, the better the
prediction.
In most cases, the number of factors is not known in advance, this is referred to as a random
model. The objective is then to select all possible important variables among numerous
and correlated X−variables which sufficiently predict the whole system. For this purpose
the leave-one-out or jackknife approach [137, 138], which focuses on the samples that leave
out one observation at a time, is widely used to determine the correct complexity of the
model, i.e., to determine the optimal number of factors avoiding the risk of “over-fitting”
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the jackknife sample, and thus, for n observations, we have exactly n jackknife samples
from which n jackknife estimates ŶJ1, . . . , ŶJn can be obtained and the jackknife prediction







The difference between actual Y and predicted ŶJ−values induced by n jackknife sample
models is computed. The cross-validation sum of squares of this difference, calculated
from all the jackknife samples, is referred to as the Predictive REsidual Sum of Squares







Thus, when using the cross-validation approach, the ratio PRESSℓ/RESSℓ−1 is calculated
after each factor and a factor is significant if this ratio is smaller than the threshold set to
(0.95)2 ≈ 0.9 [123]. RESSℓ−1 denotes the residual sum of squares before the current factor
indexed ℓ, with RESS0 = m × (n− 1) , and the computation of factors continues until a
non-significant factor is found.
Significance and Interval Estimation of the PLS Regression Coefficients
Estimating the confidence intervals and significance of the PLS parameters is an active
research area [139, 140, 141]. Using a leave-one-out cross validation approach, the variation
in the parameters of the various jackknife sample models from data can be used to estimate
standard errors, followed by the use of a t-distribution, assuming that n < 30 to determine
confidence intervals. The jackknife estimate of standard errors of the relationship score sı
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where BJℓ is the estimate regression coefficient produced from the replicate ℓ-th jackknife
sample, 1 ≤ ℓ ≤ n. And B̃ is the jackknife regression coefficient estimate which is the mean






Thus, at significance level α the confidence limits for BPLS with (1−α)× 100% confidence








where Ŝe is a matrix whose components are Ŝeı, computed in equation (2.31), and referred






is the critical value of the t−distribution
with probability 1 − α/2 for n − r degrees of freedom. Note that for the sample size or
the number of observation n ≥ 30, the normal distribution values are used instead of a
t−distribution in estimation of confidence intervals.
For the significance of the regression coefficient sı, the test can be set in the usual fashion.
So the test of interest is
H0 : sı = 0
Ha : sı 6= 0




where B̂ı is the estimated regression coefficient and Ŝeı the standard error respectively
defined in relations (2.26) and (2.31).
The decision rule is that the coefficient sı is judged significant if |t∗| > t (1− α/2;n− r) ,
with α the significance level. Alternatively, one can compute the probability value (p-
value), which is the probability of getting a value of the test statistic greater than that
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if the p-value is less than the significance level α. The latter approach has become the
standard technique for assessing the significance of predictive parameters in regression
analysis, and is incorporated in all available regression tools.
2.2.4 MTB Co-expression Network Derived from Microarray Data
The raw microarray datasets for the organism under study, namely MTB strain CDC1551,
were downloaded from the public microarray databases, Stanford Microarray Database
(SMD) [126] and NCBI Gene Expression Omnibus (GEO) [125]. We analyzed the stan-
dardized log relative intensity ratio, namely the log2 (Cy5/Cy3) with Cy5 (red fluorescent
dyes) labelling target and Cy3 (green fluorescent dyes) labelling reference samples re-
spectively. To generate MTB co-expression networks using the PLS approach described
above, we considered two experiments from the SMD database whose the file Ids are 15569
and 15575, and five experiments from the GEO database whose file Ids are GSM219305,
GSM219324, GSM219694, GSM219695 and GSM219696. These files were specifically con-
sidered as they provide the highest coverage in terms of total number of common genes
when joining the microarray expression data.
Evaluating Functional Interactions Derived
In order to assess the statistical significance of results obtained, we use a significance level
α = 0.05. The corresponding p-value of gene pair-wise interactions is computed by varying
in the parameters of the various leave-one-out sample models from initial datasets. In
the co-expression network, an edge linking two genes shows the significance dependency
between them if the p-value is less than 0.05.
For biological validation of the model, we use the assumption that a given interaction is
correctly predicted or biologically relevant if the two interacting partners belong to the
same functional class. For this we used the functional classes assigned to MTB proteins
in Tuberculist (http://genolist.pasteur.fr/Tuberculist). The number of correctly
predicted interactions is then used as a performance measure for comparing the three
models, namely under-, over-estimated, and optimal models.
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(b) Number of correctly predicted associations.
Figure 2.8: Performance analysis of the three models, Under-Optimal-Over Estimated Mod-
els.
we counted all relevant predicted associations for the three models. For the cumulative
number of correctly predicted associations, each α in the figure corresponds to the number
of associations with p-value β < α. On the other hand, for the number of correctly predicted
associations, each α corresponds to the number of associations with p-value β and α ≤
β < α, where α is the significance level just before α in the plot. These results show
that in the three models, the number of interactions correctly predicted increases with the
significance level α, and the “optimal” model outperforms the under- and over-estimated
models.
This is justified by the results shown in table 2.2, where the PLS analysis of MTB microar-
ray data is performed, evaluating on average, variance explained by latent vectors (factors
or components). These results show that in most cases, two PLS factors are enough to
explain raw MTB data, while one factor was often not enough to extract all useful informa-
tion from these data, thus missing some of the interactions. In addition, three factors were
too many, producing more noise than information needed, thus causing the inefficiency of
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Table 2.2: PLS analysis of MTB raw data.
Cumulative Cumulative
% of Explained of Explained % of Explained % of Explained
# of PLS Var. for Predictive Var. for Predictive Var. for Target Var. for Target
Factors Proteins Proteins Proteins Proteins
1 53.68 53.68 92.47 92.47
2 13.17 66.85 6.60 99.06
3 11.52 78.37 0.89 99.96
4 7.36 85.73 0.04 100.00
5 7.04 92.77 0.00 100.00
6 7.23 100.00 0.00 100.00
Table 2.3: Functional interactions in the STRING co-expression network and in our co-
expression network.
Low Confidence Medium Confidence High Confidence
STRING 763 122 0
Our Scheme 6538 225 4
Comparison with the STRING Co-expression Network
The STRING database retrieves its co-expression data from the ArrayProspector web
server (http://www.bork.embl.de/ArrayProspector), which uses a combination of sin-
gular value decomposition and kernel density estimation to compute raw log-odds scores
for functional associations between genes with the KEGG map as a reference [84]. The
number of functional interactions from the STRING co-expression network and from our
approach are shown in table 2.3. The number of biologically significant functional inter-
actions in each interval ]x/10, (x + 1)/10] of link scores, with x = 0, . . . , 9, is shown in
figure 2.9.
Indeed, all the STRING co-expression interactions are contained in our co-expression net-
work and it is not surprising to find that there are no functional interactions with high










Chapter 2. Integrative Scoring System for Sequence and Microarray Data 47





























(a) Cumulative fractions of correctly predicted as-
sociations.






































(b) Number of correctly predicted associations.
Figure 2.9: Comparison of functional interactions obtained using our approach to STRING
scheme in terms of functional category coherence.
to the fact that it may not have included all relevant MTB array data available, and it
uses the KEGG map as a reference and for the organism under study, for which many of
the genes have not yet been classified in KEGG. This also justifies the lack of functional
interactions with high confidence in the STRING co-expression network since the STRING
scheme assigns a high score to a given functional interaction if the two interacting partners
co-occur in at least one KEGG map. For this particular organism, none of the interacting
partners have been found in the same KEGG map.
2.3 Summary
We set up scoring systems for identifying and measuring functional relationships between
proteins extracted from sequence similarity, protein family and domain and microarray
data. These approaches are dynamic, data-driven and technology dependent schemes,
producing additional data to STRING for the construction of the MTB functional net-
work. We produced MTB homology and co-expression networks which can contribute to











MTB Proteome Functional Networks
Several biological studies have shown that a protein is a “social animal” [142, 143, 144, 145],
i.e., a protein does not achieve its function alone but cooperates with other proteins to per-
form that function. Therefore, annotating the function of individual proteins in isolation
is not sufficient for improving our understanding of their biological processes. Their roles
or functions must be integrated with those of other proteins for maintaining the stability
of the biological system under unchanging environmental conditions and for the robust-
ness of the system under changing conditions. Many essential cellular processes such as
signal transduction, transport, cellular motion and most regulatory mechanisms are thus
mediated by protein-protein interactions [146]. These interactions are of various types, but
a high level description of biological systems partitions them into two categories, namely
physical and functional interactions [92]. Physical interactions refer to physical contact
between proteins, and functional interactions or relationships between proteins involve the
mechanism through which a particular protein achieves its functions. While “functional
interactions” between proteins suggest direct physical contact between them [147], it is ac-
tually a broader concept and does not necessarily involve direct physical interactions [146].
In this work, we only refer to functional interactions, including genetic interactions, and
those derived from knowledge about co-expression and shared evolutionary history. Pro-
teins interact directly or indirectly through one or more intermediates to carry out their
functions in promoting the stability and robustness of the system. These interactions can
be modeled as a network, called a protein-protein functional network or interactome. This
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interactions or functional relationships between proteins within an organism. Analytically,
protein-protein functional interaction networks are represented as a couple G (N ,L) where
N is the set of proteins (nodes) and L the set of functional relationships (links), and
graphically visualized using an undirected graph layout representing the paths of commu-
nication and metabolism of an organism. Even though interaction networks do not directly
encode cellular processes nor provide information on dynamics, they do represent a first
step towards description of cellular processes, which are ultimately dynamic in nature [148]
and they constitute a significant step toward understanding the functional organization of
the cell [146]. Therefore, knowledge of protein-protein networks might advance our under-
standing of biological systems including molecular pathways, elucidate the role of various
proteins in complex diseases and how they cooperate to achieve a higher goal in the organ-
ism. This could contribute towards improving the control of disease, and thus ultimately
enhancing health.
To obtain a protein-protein interaction network, every functional relationship or interaction
between proteins should be depicted. These interactions are discovered by various exper-
imental approaches, and often partially complemented with prediction techniques [81].
One of the subjects of heated debate around protein-protein interaction networks is that
a network obtained from high-throughput experiments roughly maps the “current” net-
work of interactions occurring inside the cell. Indeed, there are several issues related to
high-throughput data including noise, environment and the nature of the approaches used
for each experiment [89]. Thus, each specific approach may incorrectly classify interac-
tions, i.e., either failing to detect interactions, referred to as false negatives or wrongly
identifying some other interactions, referred to as false positives. The lack of appropri-
ate techniques to address these shortcomings results in biases in the outputs and this is
obviously a technology-dependent problem. In order to alleviate the former issue, data
integration combining information from multiple interacting data sources into one unified
network is deployed, leading to a higher confidence and an increased coverage. For the lat-
ter issue, a reliability threshold is applied, thus discarding all functional interactions whose
reliability or confidence score is less than the threshold. These techniques are expected
to significantly reduce the false negative and positive rate of the network produced, thus
yielding a network of high confidence interactions.
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tions from several protein-protein interaction datasets in order to produce an integrated
MTB proteome network of high reliability interactions using an integrated scoring scheme.
A global view of the MTB proteome network is also discussed, analyzing the contribution
of each protein-protein interaction dataset to the network produced.
3.1 Data Sources for the Analysis of the MTB Pro-
teome
The recent availability of large amounts of biological data from primary genomic sequences
and the exponential growth of high throughput experimental datasets have made possible
the analysis of organisms with high confidence, accuracy and precision. These data are
currently gathered in the public databases freely accessible via web interfaces, and con-
stitute a rich source of knowledge which has the power to advance our understanding of
organisms. With the use of computational approaches, this has opened a new route to-
ward investigating relationships between genes and their products and eventual function
prediction of uncharacterized proteins.
In this study, we combine heterogeneous sources of biological data for the analysis of the
genome of MTB strain CDC1551. Da asets for the organism under study were downloaded
from public biological web sites provided in table 3.1. These data can be categorized into
two classes, namely genomic and functional data. Functional data include data from
STRING, Gene Ontology (GO), KEGG and MetaCyc pathways, as well as data from
high-throughput experiments, such as microarray data. On the other hand, genomic data
consists of sequence data including gene and protein sequences, and protein family and
domain data.
STRING is collection of known and predicted protein-protein associations derived from
high-throughput experimental data, the mining of databases and literature, and from pre-
dictions based on genomic analysis for a large number of organisms. As such, it provides a
very useful initial overview of the functional partners of a protein, especially for uncharac-
terized proteins [81, 82]. The Gene Ontology (GO) [87] produces a dynamic and controlled
vocabulary for consistently describing the biological context of genes and their products
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Table 3.1: Data resources for the analysis of the MTB proteome.
Scheme Description Types URL
STRING Search Tool for Retrieval of Functional associations inferred from http://string.embl.de/
Interacting Genes/Proteins sequence and high throughput data
GO Gene Ontology A classification system for annotation http://www.geneontology.org
of genes and gene products with
Molecular Function, Biological Process
and Cellular Component
BioCyc EcoCyc, MetaCyc and derivatives A Database architecture for genomes http://biocyc.org/
and pathway information
KEGG Kyoto Encyclopedia of Genes An integrated database of genes http://www.genome.jp/kegg
and Genomes and metabolic pathway information /pathway.html
for many species
UniProt Universal Protein knowledgebase Centralized resource for protein http://www.uniprot.org/
sequences and functional information
InterPro Integrated documentation res- An integrated database of motif http://www.ebi.ac.uk/interpro
ources for protein families, and domain collections
domains and functional sites
Integr8 Integr8 Project A resource for genomic and http://www.ebi.ac.uk/integr8
proteomic data
SMD Stanford Microarray Database A database storing raw and normalized http://smd.stanford.edu/
data from microarray experiments
GEO Gene Expression Omnibus A database repository of high http://www.ncbi.nlm.nih.gov/geo/
throughput gene expression data and
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(CC). The systematic analysis of gene and protein biochemical functions is obtained from
KEGG [83] and MetaCyc [149], covering most of the known metabolic and regulatory
pathways. Microarray data used to construct the co-expression network of the organism
under study were downloaded from the public microarray databases Stanford Microarray
Database (SMD) [126] and the NCBI Gene Expression Omnibus (GEO) [125].
Genomic data used were obtained from the InterPro and UniProt databases downloaded
from the Integr8 project at European Bioinformatics Institute (EBI)(http://www.ebi.ac.
uk/integr8). The Integr8 project offers an overview of complete genomes and proteomes
and has been designed to capture data from different molecular biology databases [150].
Our analysis is performed using the non-redundant complete list of proteins extracted
from the UniProt database [151] and protein family data is from InterPro. InterPro [85]
integrates together predictive models or signatures representing protein domains, families
and functional sites, from multiple source databases, namely, PROSITE, Pfam, PRINTS,
ProDom, SMART, TIGRFAMs, PIRSF and SUPERFAMILY, Gene3D, PANTHER [86].
3.2 Functional Interaction Datasets
Analyzing a cell or an organism functioning as an integrated system is becoming more and
more important since it allows identification of patterns or properties driving the system.
This requires the combination of biological experiments and computational methods in
order to determine the complete set of interactions existing between all the proteins in
the organism. In this study, we use computational approaches to predict pair-wise protein
functional associations depending on the data types, which can be divided into the following
three categories.
1. Sequence data by using pair-wise sequence similarity and domain data.
2. Genomic context data, which includes conserved genomic neighbourhood, gene fusion
events and phylogenetic distribution patterns.
3. High throughput data providing interactions derived from microarray (co-expression)
analysis, text mining, knowledge from pathway databases, and known physical inter-
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The functional interactions produced are partitioned into two classes, namely interactions
extracted from the STRING database and those derived from sequence and microarray
data, using the scoring schemes developed here, and considered to be additional interac-
tions to STRING data. Functional interactions extracted from STRING are comprised
of interactions derived from genomic context (genomic conserved neighbour or gene or-
der, gene fusion events and gene co-occurrence or phylogenetic profiles across genomes),
text mining, knowledge from pathway databases, and known experimental interactions.
Thus, the network is obtained by combining the interactions generated by exploiting 9
different approaches (listed in table 3.2) and each interaction is scored according to the
computational approach used to derive it. Understanding the properties of these functional
interactions is key to successful mathematical modeling of such a system and developing
efficient scoring techniques.
The underlying idea of exploiting the conserved gene neighbourhood or gene order approach
to predict functional association between proteins is that proteins whose genes are found to
be close to each other across multiple genomes are likely to be involved in the same complex
or process or to act in the same functional pathway. Thus, these proteins are expected to
interact functionally [152]. This is biologically founded on the fact that proximity between
genes is the dominant strategy for identifying an operon in the genome [153]. An operon is
a group of genes transcribed in a single messenger RNA (mRNA) and often encodes genes
in the same functional pathway [154].
The gene fusion method is another approach that uses the relative positioning of genes in
a genome, indicating that if two separate genes in one organism exist as one fused gene in
another, then these genes are likely to be functionally related [147]. The reasoning behind
this approach is that the fusion of two genes from organism to one another indicates that
these genes work together and thus have possibly evolved under common selective pressure
and are thus more likely to be functionally linked.
The phylogenetic profile or gene co-occurrence approach models the representation of copies
(homologs) of a given gene inherited across organisms during speciation events under strong
selective pressure [155]. The presence of a copy in a given organism is represented by 1
and the absence by 0, thus producing the phylogenetic profile or evolutionary path of the
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profiles, i.e., present together, are more likely to function together in a functional pathway
or protein complex, and they are thus expected to be functionally associated [156].
Text mining is the process of extracting semantically interesting and non-trivial knowl-
edge from unstructured text [157]. Robust data analysis approaches, such as classification
and clustering, are used to handle large variations in the extraction of the information
from text data. A functional relationship between genes is predicted by representing
each gene by a set of abstracts and comparing the sets of abstracts of pair-wise genes
to determine their functional relationship based on the frequency of co-occurrence. In
STRING, abstracts from PubMed, which contain MEDLINE documents with approxi-
mately 11 million biomedical citations covering over 4600 biomedical journals published
worldwide [158], are used for systematically searching gene names and aliases [81] on NCBI
Entrez (http://www.ncbi.nlm.niv.gov/entrez).
The intuition behind interaction data derived using knowledge from pathway databases
and known physical interactions is to retrieve interaction data from pathway maps and
known physical interaction datasets from high throughput experiments. For this purpose,
the STRING database retrieves these interaction data from the KEGG and DIP databases.
Note that the Database of Interacting Proteins (DIP: http://dip.doe-mbi.ucla.edu) is a
database that documents experimentally determined physical protein-protein interactions,
providing an integrated set of tools for extracting information about physical protein in-
teraction networks [159]. With respect to KEGG maps, two proteins are considered to be
functionally related if they co-occur in at least one KEGG map.
Finally, the basis underlying the other three methods, namely sequence similarity, shared
domains and microarray co-expression scoring schemes has been discussed in chapter 2.
3.3 Construction of the MTB Functional Network
A unified scheme has been defined in order to normalize or standardize the protein pair-wise
relationship confidence scores from nine different sources taking into account the nature
of experiments used to derive them. This scheme has an impact on the final functional
similarity between interacting partners, which depends on biological data source. The
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Pathway information
MTB Data Integration Scheme
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Figure 3.1: Data accession scheme.
confidence scores when taking into account the experiment used to derive them. For ex-
ample, sequence data are more likely to reveal similarity of molecular functions between
pair-wise interacting proteins, while genomic context data may indicate sharing of biolog-
ical process or pathway functional connections rather than exact molecular functions [89].
Nevertheless, as we are expecting our confidence to increase, especially when the functional
relationship is predicted from at least two different data types, the combined link confi-
dence score between two proteins ı and  for an integrated view of all datasets through a








under the assumption of independency, and where sdı is the confidence score of functional
interaction between ı and  predicted using the type of data d.
Using this combined score, protein pair-wise functional interactions derived from nine
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on its source, were integrated into a single network and stored in a local MySQL database
accessible via a web interface at http://lab12.cbio.uct.ac.za/tbannotations_v2/, as
described in figure 3.1. Based on this integrated network and a user defined query protein
of interest, all proteins in direct relationships with the query protein are identified and
displayed together with other functional information related to the query, namely pathway
information, annotation from GO and matches to InterPro signatures. The main page of
this web interface and an example of the output interface are shown in figures 3.2 and 3.3,
respectively.
Figure 3.2: The main page of the web interface allowing the user access to MTB protein
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Figure 3.3: An example of the output format for a given protein. The status indicates that
a protein is of known functional class, in which case, its status is 1, 0 for those of unknown
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Table 3.2: The number of associations in the MTB functional network, shown separately
for each data source and confidence range from low to high.
Association Evidence by Type Low Confidence Medium Confidence High Confidence
Conserved genomic neighbourhood 1163 6972 4731
Gene fusion events 337 52 99
Phylogenetic Profile 1033 5862 1461
Text mining 1174 722 93
Experimental 220 170 133
Knowledge from database 3 970 2002
Sequence similarity 8524 1345 77
Shared domains 0 20915 17792
Co-expression 6538 225 4
Combined Score 6850 32488 25605
3.4 General View of the MTB Functional Network
We have constructed the MTB functional network from nine biological data sources. The
number of functional interactions between proteins derived from these data sources and
divided into three different confidence categories, namely low, medium and high confidence
is shown in table 3.2.
The final row shows the number of interactions in each confidence range for the final
combined score. Note that for a given data source, all interactions whose scores are strictly
less than 0.3 (< 0.3) are considered as low confidence, and scores ranging from 0.3 to 0.7
(0.3 ≤ score ≤ 0.7) are classified as medium confidence and scores greater than 0.7 (> 0.7)
yield high confidence. Furthermore, the confidence increases when interaction data are
integrated into a single network, producing more medium and high confidence links in the
last row than when considering only one type of data.
The use of these nine different biological sources is expected to solve the problem of in-
teraction incompleteness. On the other hand, to reduce the impact of bias in functional
interactions coming from experimental predictions and computational approaches, we have
only considered those ranging from medium to high confidence and for functional interac-
tions with low confidence, only those predicted by at least two different approaches were
considered. In total, 5 interactions of low confidence predicted by at least two different
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Table 3.3: General MTB functional network parameters.
Parameters Value
Number of Proteins (Nodes) 4136
Number of Functional Interactions (Edges) 58098
Average Degree (in and out) 28
Average Shortest Path Length 3.678
Number of Connected Components 23
% of Nodes in Largest Component 98.7%
Number of Hubs 201
general properties and these network parameters are presented in table 3.3.
The network is comprised of 4136 proteins out of 4195 found in the complete list from
UniProt, covering approximately 98.6% of the MTB proteome. Of these, 201 are structural
hubs, or “single points of failure”, which are able to disconnect the network, thus affecting
function, and they are considered to be responsible for the integrity of the system. Due to
the presence of these hubs, any pair-wise protein set in a given connected component can
communicate through its relative shortest paths. A shortest path between two nodes is the
minimum number of hops (edges) required to get to one node from another node. In the
MTB functional network, the average path length, obtained by averaging over all shortest
paths between all pairs of nodes, is approximately 4 as shown in figure 3.4 representing
the probability distribution of the shortest path length.
This reveals that the transmission of biological information from a given protein to others is
achieved through only a few steps. Indeed, the average shortest path length value is 3.678,
which is approximately of the order of magnitude log (|N |) with |N | = 4136. This means
that the MTB functional network has a ‘small world property’ [160, 161] and provides an
idea about the network navigability, indicating how fast the information can be spread in
the system independently of the number of proteins. This property may also provide the
organism with an evolutionary advantage in the sense that the system would be able to
efficiently respond to perturbations in the environment and to quickly exhibit a qualitative
change of behaviour in response to these perturbations.
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Figure 3.4: Distribution of shortest path lengths between reachable pair-wise protein func-
tional interactions.
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Figure 3.5: Connectivity distribution of detected k functional links per protein, plotted as
a function of frequency P (k).
and, as shown in figure 3.5, the functional network exhibits scale-free topology, i.e., the
degree distribution of proteins approximates a power law P (k) = k−γ, with the degree
exponent γ ∼ 1.45. This means that most of the proteins have few interacting partners but
some have many partners. The latter are referred to as “high degree nodes”, and probably
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for the survival of the organism.
3.5 Summary
In this chapter, we integrate functional interactions derived from different biological sources
and using computational approaches into a single functional network via the computation
of final relationship scores under the independence assumption. This is expected to solve
the problem of functional interaction incompleteness of individual data sources. Taking
into account the fact that some of these data are unreliable, the functional interactions
considered for further analysis are those with a final score ranging from medium to high
confidence and those with lower confidence but predicted by at least two different ap-
proaches. The global view of the structure of the network produced shows that it satisfies
the ‘small world’ property and exhibits a ‘power law’ distribution. The network is available
for searching via a web interface at http://lab12.cbio.uct.ac.za/tbannotations_v2/,











Functional Analysis of the MTB
Proteome Networks
Proteins perform an astonishing range of biological functions in an organism. These include
roles as structural proteins, enzymes and for the transportation of materials within and
between cells [78]. Each protein is a gene product that interacts with the cellular environ-
ment in some way to promote the cell’s growth and function [162]. Therefore, knowledge
of protein functions and their biological pathways is crucial for understanding pathogen
behaviour and thus for therapeutic study, enabling the development of new drugs.
Despite ever-increasing amounts of biological data including primary data, such as genomic
sequences, and functional genomic data from high throughput experiments, there is a defi-
ciency in functional annotation for many newly sequenced proteins. For instance, in most
bacterial genomes, as many as 40% of identified proteins are labeled “uncharacterized” or
“unknown” or “hypothetical” proteins [163] and specifically, about half of the Mycobac-
terium tuberculosis genome is made up of proteins of unknown functions. This limits the
ability to exploit these data, leading to the paradigm of “a world which is data rich yet
information poor”. Thus, one of the major tasks in the post-genomic era is genome an-
notation, assigning functions to gene products based mostly on amino acid sequence, in
order to capitalize on the knowledge gained through these sequencing efforts. However,
experimentally determining the function of these proteins is likely to be difficult for sev-
eral reasons. These include [164]: (1) possible specific relationship of the function to the
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the genome for securing its survival in a particular environment, which may have no use in
the environment created in the laboratory, and (3) it may even, in many cases, be almost
impossible to imitate the natural host, with its myriad other micro-organisms, and thereby
determine the exact function of gene or gene product by experiment alone. The only ef-
fective route toward the elucidation of the function of uncharacterized proteins may be a
combination of experimental approaches and predictions through computational analysis.
With the huge amount of data generated over the years, function prediction of identified
but yet uncharacterized proteins requires an automated mechanism able to infer functions
from related proteins of known functions on the basis of their functional associations or
relationships. The framework of our system to achieve this, as described in figure 4.1
follows these steps:
• Generate Functional Interaction Networks enhanced by integrating data from het-
erogeneous sources (Homology-based, Genomic context and High throughput data).
• Using Gene Ontology (GO) and incorporating pathway information, predict functions





















Figure 4.1: System framework for protein function prediction.
Predictions along these lines will give a first hint towards functionality that later can be
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The progress made in the use of computational approaches to predict protein function from
diverse types of biological data has positively impacted the functional genomics research
field. There have been several cases of functional inference in which functions predicted
computationally were experimentally validated [165].
Sequence similarity search tools, such as Basic Local Alignment Search Tool (BLAST) [75],
have been extensively used for predicting functions of uncharacterized proteins. This
approach is referred to as homology-based annotation transfer, providing an easy and
straightforward scheme of suggesting possible functions for uncharacterized proteins. The
key assumption driving this approach is that two proteins with significantly similar se-
quences are evolutionary linked and might thus share common functions. However, many
factors limit its applicability. For example, no known sequence may be similar to the novel
protein sequence in the database, and above all, the most significant database hit may per-
form a different function due to gene duplication events [142, 166, 167], domain shuffling
events (deletions), or single point mutations [168]. As a consequence, on the computa-
tional side, the inability of accurately inferring protein functions leads to the propagation
of annotation errors in the database [169]. Several approaches that do not rely directly
on sequence similarity have also been implemented [170]. These include using information
about gene fusions, phylogenetic profiles of proteins families, gene adjacency in genomes
and expression patterns. In this work, we are following a data integration approach based
on functional networks, which provides the opportunity to exploit all these approaches for
characterizing proteins of unknown function.
In the following section we describe the concept of protein function, survey the Gene
Ontology (GO), and set up a novel GO semantic similarity metric in order to measure
GO term closeness in the hierarchy of GO directed acyclic graph (DAG). Thereafter, we
perform functional analysis of the MTB functional network through function prediction,
where possible, of uncharacterized proteins in the MTB proteome. We use a prediction
approach judged to be the best in terms of quality of prediction and genome coverage.
Finally, we provide a new predicted functional classification of the MTB genome strain
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4.1 Protein Function and Gene Ontologies
Mathematically, a set X is a well-defined collection of objects and a function f from a
set A to a set B is a rule which associates to each objects (input) x ∈ A at most one
object (output) y ∈ B. In this case, y represents the realization of x, called a function of x
and denoted y = f (x) . Thus, for a function to be well-defined, we need to know the two
sets A and B and the rule of associations of objects or realizations of all objects of A. In
addition, if the sets A and B are well described, a function f is completely determined by
knowing just the realizations of objects. Similarly, assuming the context and the scope of
interest are known, protein function is a concept used to describe all type of realizations
or activities to which the protein contributes.
Indeed, even from a biological point of view, the activity to which a protein contributes
takes place within an organism and has consequences ranging from the cellular level to
the whole organism. This means that the “protein function” concept has various aspects.
Firstly, the location where a protein is performing its function must be known and then
its contribution has to be categorized. For instance, a protein may be considered to be
an enzyme in a given biochemical reaction inside the cell and this is referred to as the
biochemical or molecular function of a protein. A protein may contribute to complex
physiological reactions within metabolic pathways as a component of a complex or via
interactions with other proteins in a cell, guaranteeing an efficient functioning of the or-
ganism. This is referred to as its cellular function. Furthermore, as a component of an
integrated physiological system, a change in protein due to the response of the system to
perturbations or environmental stimuli determines the phenotypic output of the organism;
this is referred to as the phenotypic function [171]. This demonstrates the subjectivity and
ambiguity of the concept “protein function” without describing the context and the scope
of interest. Therefore, protein function assignment requires the characterization of protein
contributions using well-defined and structured vocabularies specifying the aspect and the
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4.1.1 Description of Protein Function
As mentioned previously, for good characterization of protein function we need to de-
scribe its attributes in a systematic manner using a standardized syntax and semantics
in a format that is human readable and understandable, as well as being interpretable
computationally. The terms used for describing a function should have definitions and be
placed within a structure of relationships [172]. Therefore, an ontology is required in order
to represent annotations of known genes and proteins, and to predict functional annota-
tions of those which are identified but so far uncharacterized. An ontology is an explicit
specification of concepts that includes a set of objects, their properties and their values
along with describable relationships between them. This is reflected in a representational
vocabulary for a specific domain, containing definitions of classes, relations, functions and
other objects [173, 174, 175, 176, 177]. An ontology may be simplified in a hierarchical
classification showing the type subsumption relations between concepts in the field of dis-
course, and visualized as an abstract graph with nodes and labeled arcs representing the
objects and relations.
By capturing the knowledge about a domain in shareable and computationally accessible
form, ontologies can provide defined, accessible and computable semantics about the do-
main knowledge they describe [172]. Thus in biology, ontologies are expected to produce an
efficient and standardized functional scheme for describing genes and gene products. The
earliest controlled vocabulary and well-defined protein function relationships scheme arose
from the biochemistry field in the form of the Enzyme Commission (EC) classification [178].
An EC term is used to classify enzymes in biochemical reactions from a unique identifier
with a four-level hierarchy of the form “EC -.-.-.-”, starting from the more general in the
first position, representing a class of enzymes responsible for the catalysis of metabolic
reactions, to the more specific in the fourth position specifying the precise biochemical
reaction in which a particular enzyme is involved. Unfortunately, this scheme is essentially
limited to the classification of protein enzymatic function in biochemical reactions. Thus,
several other functional schemes have been suggested [179, 180] for a wider class of genes
and gene products with the common objective of setting up an ontology for gene anno-
tations. Structured and controlled vocabularies provide the ability to explore functional
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gies are currently more generalized and more widely applicable due to the unification of
biology and the information about genes and proteins shared by different organisms, most
of them were initially designed for specific organisms in order to exploit the biological
properties of their genomes. For example, EcoCyc [181, 182, 183] was originally set up to
categorize gene products of Escherichia coli K12 (E. coli).
Generally, a more widely applicable ontology should be designed to cover a wide range of
organisms, ensuring the integration of biological phenomena occurring in a wide variety
of biological systems. In addition, it must be dynamic in its nature in order to enable
the design to incorporate new knowledge of gene and protein roles over time. One of the
biggest accomplishments in this area is the creation of the Gene Ontology (GO) [87], which
currently serves as the dominant and most popular functional classification scheme [91, 184]
for annotation and functional representation of genes and their products. In this work, we
make use of GO terms to predict, where possible, functions of a large number of proteins
of unknown function in Mycobacterium tuberculosis.
4.1.2 Gene Ontology (GO)
The necessity for organizing and unifying biology and information about genes and proteins
shared by different organisms has led to the construction of the Gene Ontology (GO) [87].
At its outset, GO aims at producing a dynamic, structured and controlled vocabulary
describing the role of genes and their products in any organism, thus allowing humans and
computers to resolve language ambiguity.
GO provides three key biological aspects about genes and their products in a living cell,
namely, the complete description of the tasks that are carried out by individual proteins,
their broad biological goals, and the subcellular components, or locations where the activi-
ties are taking place. Thus, GO consists of three distinct classification schemes, molecular
function (MF), biological process (BP) and cellular component (CC) [185], each engineered
as a Directed Acyclic Graph (DAG), allowing a term (node) to have more than one single
parent in order to characterize those involved in several molecular functions, biological
processes, and subcellular locations. Traditionally, there are two types of relationships










Chapter 4. Functional Analysis of the MTB Proteome Networks 68
Table 4.1: GO evidence codes.
Class Category Evidence
Manually-assigned Experimemtal EXP: Inferred from Experiment
IDA: Inferred from Direct Assay
IPI: Inferred from Physical Interaction
IMP: Inferred from Mutant Phenotype
IGI: Inferred from Genetic Interaction
IEP: Inferred from Expression Pattern
Computational Analysis ISS: Inferred from Sequence or structural Similarity
ISO: Inferred from Sequence Orthology
ISA: Inferred from Sequence
ISM: Inferred from Sequence Model
IGC: Inferred from Genomic Context
RCA: Inferred from Reviewed Computational Analysis
Author Statements TAS: Traceable Author Statement
NAS: Non-traceable Author Statement
Curatorial Statements IC: Inferred by Curator
ND: No biological Data available
Automatically-assigned IEA: Inferred from Electronic Annotation
Obsolete NR: Not Recorded
class or an instance of the parent, and the “part of” relation indicating the child is a
component of a parent. Thus, each edge in a GO DAG represents either an “is a” or a
“part of” association between terms, and each term (node) has an unique identifier of the
form “GO:xxxxxxx”, with “xxxxxxx” a zeros padded integer of seven digits [187]. Another
relationship has emerged, namely “regulates”, which includes “positively regulates” and
“negatively regulates”, and provides for relationships between regulatory terms and their
regulated parents [186, 188]. As we are only interested in the GO DAG topology, we only
refer to the relations ‘is a’ and ‘part of’ here, and these are treated equally. Unless spec-
ified explicitly, in the rest of this work NGO and LGO will respectively express the set of
GO terms and links, and [x, y] ∈ NGO indicates that the level of term x is lower than that
of y. Considering the daily updates of the GO database, we need to mention that the GO
data used here were downloaded from the GO database on the 20th of October 2009.
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in genomics and proteomics. This growth of popularity is mainly owed to the fundamental
organization principles and functional aspects of its conception displayed by its wide cov-
erage and biological relevance. Specific tools, such as the AmiGO browser [189, 190], have
been developed for making GO easy to use, and have significantly contributed to the large
expansion of GO in the experimental and computational biology fields. Nowadays, GO is
the most widely adopted ontology by the life science community [191], and this superiority
of GO has been proven by successes resulting from its use in protein function prediction.
The GO annotation project arose in order to provide high-quality annotations to gene prod-
ucts, and is applied in the UniProt knowledgebase (UniProtKB) and International Protein
Index (IPI) [192, 193, 194, 195]. It also provides a central dataset for annotations in other
major multi-species databases, such as Ensembl and NCBI [196, 197]. The reliability or
confidence score of the annotation is embodied through evidence codes indicating how the
annotation was assigned. The GO Consortium divides these evidence codes into three
classes [198], manually-assigned, automatically-assigned and obsolete evidence codes; and
manually-assigned evidence codes, in turn, fall into four categories: experimental, com-
putational analysis, author statements, and curatorial statements. Table 4.1 presents a
complete list of these evidence codes. Note that among these evidence codes, only IEA
(Inferred from Electronic Annotation) is not assigned by a curator and is therefore of the
lowest quality.
4.2 Structuring GO for Protein Function Prediction
Considering the wide use of GO, the issues related to its design and usage have been
qualified as critical points [199] to be taken seriously for effectively deploying GO in genome
annotation analysis. One of the issues is associated with the depth of GO, which often
reflects the vagaries in different levels of biological knowledge, rather than anything intrinsic
about the terms [172]. Consequently, two genes or proteins may be functionally identical
or similar, but technically annotated and labelled with different GO Ids. If only exact
matches to GO terms are used in function prediction then these cases are lost. Although
several approaches have been designed to assess the similarity and correlation between
genes [200, 201, 202, 203, 204, 205] using their sequences or gene expression patterns from
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discovering functional similarities of genes based on their GO annotations derived from
heterogeneous data sources. Indeed, an effective approach should be able to consider the
issue related to the depth of the GO DAG (for example where a path goes singly down
the hierarchy without branching off) and provide a clear relation of how similar a parent
and child are using only the GO DAG topology. This should apply to gene or protein GO
annotations derived from different sources, and be independent of the size of the GO DAG,
as GO is expanding and increasing in size.
4.2.1 Existing GO Semantic Similarity Measures
Several GO-term similarity measures have been proposed for characterizing similar terms,
each having its own strengths and weaknesses. These similarity measures are partitioned
into edge- and node-based approaches according to Pesquita et al. [191]. While edge-
based similarity measures are based mainly on counting the number of edges in the graph
to get the path between two terms, they suffer from the fact that nodes and edges are
uniformly distributed, and edges at the same level correspond to the same semantic distance
between terms. The node-based approaches use a concept of information content, also
called semantic value, to compare the properties of the terms themselves and relations to
their ancestors or descendants, and these measures are referred to as IC-based (Information
Content-based) approaches [206]. We are interested in IC-based approaches and, unlike the
graph-based or hybrid approach introduced by Wang [207], which is based on the intrinsic
structure of the GO DAG, i.e, only uses the GO DAG topology to compute the semantic
similarity, other measures do not consider only the topology of the GO DAG. Most of them
are adapted from Resnik [208] or Lin’s [209] methods, in which the information content
(or semantic value) of a term conveying its biological description and specificity is based
on the annotation statistics related to the terms [172, 210], and thus they have a natural
singularity problem caused by orphan terms. Here these approaches are referred to as
Resnik-related approaches, whose information content or semantic value of a given term z
in the ontology, is computed as
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where p(z) is the frequency of occurrence of the term z in the genome under consideration.
Resnik’s semantic similarity between two terms x and y is given by
SR (x, y) = max
z∈A(x,y)
(− ln (p(z))) (4.2)
where A (x, y) is the set of common ancestors to terms x and y, and that of Lin is calculated
as




ln (p(x)) + ln (p(y))
)
(4.3)
Therefore, the more often the term is used for annotation, the lower its semantic value,
and as pointed out by Wang, this may lead to different semantic values of the GO terms
for heterogeneous data, whereas each biological term in the ontology is expected to have
a fixed semantic value when used in genome annotation. The semantic value is defined as
the biological content of a given term, and this may be a serious issue. This is especially a
problem due to the hierarchical structure of the GO DAG if the information will be used to
predict functions of uncharacterized proteins in the genome, in the sense that one source
can annotate a given protein with a term at a low level and another source with a term
at a higher level in the hierarchy. Furthermore, the description and the specificity of a
given term in GO essentially depends on its GO annotation specification, translated by its
position in the GO DAG structure or topology.
To overcome these limitations, Wang introduced a topology-based semantic similarity mea-









1 if t = z
max{ωe ∗ Sz (t′) : t′ ∈ Ch (t)} otherwise
(4.5)
with Ch (t) the set of children of the term t, and ωe the semantic contribution factor for
‘is a’ and ‘part of’ relations set to 0.8 and 0.6, respectively. The semantic similarity of the
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ICW (x) + ICW (y)
(4.6)
It has been shown that the Wang et al. approach performs better than Resnik’s approach
in clustering gene pairs according to their semantic similarity [207, 206].
However, a general limitation common to all these semantic similarity measures is that none
of them fully address the issue related to the depth of the GO DAG as stated previously,
i.e, the depth sometimes reflects vagaries in different levels of knowledge. An example
is where the structure is just growing deeper in one path without spreading sideways,
in which case terms going down the DAG should have the same semantic value or be
topologically identical. Here we are introducing a new semantic similarity measure of GO
terms, referred to as topological information of GO terms and based only on the GO DAG
topology, to determine the functional closeness of genes and their products based on the
semantic similarity of GO terms used to annotate them. This measure incorporates position
characteristic parameters of GO terms to provide an unequivocal difference between more
general terms at the lower level, or closer to the root, and more specific terms at the higher
level, or further from root node. Furthermore, this new measure is a hybrid node- and
edge-based approach, overcoming not only the issue related to the GO DAG depth, as
stated above, but also the issues related to the dependence on the annotation statistics
of node-based approaches and those related to edge-based approaches in which nodes and
edges are uniformly distributed.
4.2.2 GO-Universal Semantic Similarity Metric
To overcome the issue of depth of the GO DAG sometimes just reflecting the vagaries of
biological knowledge, we are introducing a topological identity or synonym term measure
referred to as its topological information. This measure is used to define a novel GO-term
semantic similarity measure in order to ensure effective exploitation of the large amounts of
biological knowledge that GO offers. This, in turn, provides a measurement of functional
similarity between proteins on the basis of their annotations from heterogeneous data using










Chapter 4. Functional Analysis of the MTB Proteome Networks 73
annotation.
Topological Information of a GO Term
Translating the biological content of a given GO term into a numerical value, called the
semantic value or topological information, on the basis of its location in the GO DAG,
requires complete knowledge of its immediate parents’ topological position characteristics.
This leads to a recursive formula for measuring topological information of a given GO
term, in which the child is eventually expected to be more specific than its parents. The
more children a term has, the more specific its children are compared to that term, and
the greater the biological difference. Also, the more parents a term has, the greater the
biological difference of this term to each of its parent terms. The three separate ontologies,
namely, Molecular Function (MF), Biological Process (BP) and Cellular Component (CC)
with GO Ids GO:0003674, GO:0005575 and GO:0008150 respectively, are roots for the
complete ontology, located at level 0, considered to be the reference level, and are assumed
to be biologically meaningless.
Definition 4.1. The topological information τ (z) of a given term z ∈ NGO is computed
as
τ (z) = − ln (µ (z)) (4.7)
⋆
where µ (z) is the topological position characteristic of z, recursively obtained using its
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and δx is an x−children indicator function, i.e.,
δx (y) =
{
1 if y is a child of x, i.e., (x, y) ∈ LGO
0 otherwise
The topological position is thus a function µ : NGO −→ [0, 1], such that for any term
t ∈ NGO, µ (t) defines a reachability measure of an instance of term t. And obviously, µ is
monotonically increasing as one moves up the three, that is if t1 is a t2 then µ (t1) ≤ µ (t2) .
For the top node or root, the reachability measure is 1.
Definition 4.2. Let [x, y] ∈ NGO, x and y are topologically identical or synonym terms,
and denoted x
GO
= y, if the following properties are satisfied.
• τ (x) = τ (y) or µ (x) = µ (y)
• There exists one path pxy from x to y. ⋆
So, two GO terms are equal if and only if they are either the same or topologically identical
terms. Suppose that there exists a path pxy from term x to term y, x is a more general
term compared to y or y is more specific compared to x, and denoted x
GO
< y if τ (x) < τ (y)
or µ (y) < µ (x).
Furthermore, the topological position µ provides a new way of assessing the intrinsic close-
ness of GO terms. Two terms in the GO DAG may share multiple ancestors as a GO
term can have several parents through multiple paths. So, assuming that a given term x
is its own ancestor, we define the topological position µs (x, y) of x and y as that of their
common ancestor with the smallest topological position characteristic, i.e.,
µs (x, y) = min {µ (t) : t ∈ A (x, y)} (4.9)
where A (x, y) is the set of ancestral terms shared by both terms x and y, and containing
x and y. Finally, the semantic similarity score of the two GO terms is given by
SGO (x, y) =
τ (x, y)
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with τ (x, y) = − lnµs (x, y) the topological information shared by the two concepts x and
y.
Clearly, the values of this semantic similarity measure range between 0 and 1, i.e., 0 ≤
SGO (x, y) ≤ 1, and for any GO-terms x, y, and z in the GO-DAG, SGO satisfies the
following property:






Figure 4.2: General Structure of Minimum Spanning Tree for 3 GO terms x, y and z in
the GO DAG. This provides a general representation of 3 GO terms in the GO DAG with
a minimum number of edges. - - - means that the branches can go down as low as they
can and —— shows the possible existing branches.
The general structure of the minimum spanning tree representing the three GO terms x,
y, and z in the GO DAG is given by figure 4.2, other cases are mapped to it. For these
three GO terms, the following 6 cases are possible: ICT (z) ≤ ICT (y) ≤ ICT (x), ICT (z) ≤
ICT (x) ≤ ICT (y), ICT (y) ≤ ICT (z) ≤ ICT (x), ICT (y) ≤ ICT (x) ≤ ICT (z), ICT (x) ≤
ICT (z) ≤ ICT (y) or ICT (x) ≤ ICT (y) ≤ ICT (z). Let’s consider the first case, if ICT (z) ≤
ICT (y) ≤ ICT (x) then max{ICT (x) , ICT (y)} = ICT (x), max{ICT (x) , ICT (z)} = ICT (x),
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ICT (y,z)
ICT (y)






≤ 1 + ICT (x, y)
ICT (x)
Finally putting everything together, we have:
ICT (x, z)
max{ICT (x) , ICT (z)}
+
ICT (y, z)
max{ICT (y) , ICT (z)}
≤ 1 + ICT (x, y)
max{ICT (x) , ICT (y)}
Meaning that
SGO (x, z) + SGO (z, y) ≤ 1 + SGO (x, y)
The same reasoning can be applied to the other cases.
The quantity dGO (x, y) = 1 − SGO (x, y) satisfying 0 ≤ dGO (x, y) ≤ 1 defines a metric or
distance on NGO. The following properties are satisfied:
(i) Positive definiteness: as 0 ≤ SGO (x, y) ≤ 1, we have 1 − SGO (x, y) ≥ 0 meaning that
dGO (x, y) ≥ 0.
(ii) Symmetry axiom: as SGO (x, y) = SGO (y, x), we have 1 − SGO (x, y) = 1− SGO (y, x),
which means that dGO (x, y) = dGO (y, x).
(iii) Identity axiom: dGO (x, y) = 0 implies 1−SGO (x, y) = 0, meaning that SGO (x, y) = 1,
which implies that x
GO
= y.
(iv) Finally, sub-additivity or triangle inequality: from the relation (4.11), we know that
0 ≤ SGO (x, z) + SGO (z, y) ≤ 1 + SGO (x, y). It follows that
− [1 + SGO (x, y)] ≤ − [SGO (x, z) + SGO (z, y)]
Adding 2 on both sides, we have 1−SGO (x, y) ≤ [1− SGO (x, z)] + [1− SGO (z, y)], which
means that dGO (x, y) ≤ dGO (x, z) + dGO (z, y).
This metric is referred to as the GO-universal metric, and the more topological information
two concepts share, the lower their distance and the more similar or closer they are. More-
over, the similarity formula in (4.10) emphasizes the importance of the shared GO terms
by giving more weight to the shared ancestors corrected by the maximum topological in-
formation, and thus measuring how similar or close each GO term is to another. Thus, for
two GO terms sharing less informative ancestors the distance is higher and the similarity
smaller, while for two GO terms sharing more informative ancestors, they are closer and
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a given parent to the term depends on the parent reachability measure. The smaller the
reachability measure of that parent and the lower the number of children it possesses, the




















(1/3456, 8.15) (1/3456, 8.15)
(1/1728, 7.45)(1/82944, 11.33)
Figure 4.3: Hierarchical structure illustrating how to compute topological position charac-
teristic and information. Nodes are numbered from 0 to 11 with 0 as a root. The numbers
beside each node represent its topological position characteristic and information content.
To illustrate the way this approach works, consider the hierarchical structure as shown in
figure 4.3. In this DAG from top to bottom, we have:
- The topological position characteristic of the root 0, µ(0) = 1, and so its topological
information is τ(1) = − ln(1) = 0.
- As 1 and 2 have only parent 0, which has only these two children with µ(0) = 1, this
yields: µ(1) = 1/2 = µ(2), and so their topological information is τ(1) = − ln(1/2) =
0.69315 = τ(2).
- 3 has only one direct parent 1, with µ(1) = 1/2 and two children, we have: µ(3) = 1/4
and its topological information is then τ(3) = − ln(1/4) = 1.38639.
- 4 has two direct parents 1 and 2. 1 has two children with µ(1) = 1/2 and 2 has three
children with µ(2) = 1/2. Thus, its topological position characteristic is the product of
topological characteristic position of its parents respectively divided by the number of
children for each parent µ(4) = (1/4) ∗ (1/6) = 1/24 and its topological information is
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- 5 has only one direct parent 2, which has three children and µ(2) = 1/2. Its topological
position characteristic is µ(5) = 1/6 and its topological information is τ = − ln(1/6) =
1.79176.
Unlike edge-based approaches where nodes and edges are uniformly distributed, and edges
at the same level of the ontology correspond to the same semantic distance between
terms [191], in this new approach these parameters depend on the topological position
characteristic of terms, which are not necessarily the same. In this illustration, nodes 3, 4
and 5 are at the same level but they do not have the same topological position character-
istic, thus leading to different topological information or semantic values.
Furthermore, the above illustration reveals that the product in formula (4.8) of topolog-
ical position characteristic must be carefully taken into account hen implementing the
approach since the exponential tail-off with increasing depth is severe depending on the
density of the hierarchical structure under consideration. Here, we suggest computing
µ(z) iteratively when performing this product and every time the multiplication is done,
the obtained value must immediately be converted to a pair of numbers (α, β) such that
µ(z) = α10β with 0.1 ≤ α < 1 and β < 0. This means that every time the product is per-
formed, the new value is converted to this format so that at the end, the topological position
characteristic is just given by (α, β) such that µ(z) = α10β and τ = − ln(α)− β ln(10).
Functional Closeness of Proteins
A given protein may perform several functions, thus requiring several GO terms to describe
these functions. For characterized or annotated pair-wise proteins with known GO terms,
functional closeness or GO similarities based on their annotations, and consequently the dis-
tances between these proteins can be evaluated using the Czekanowski-Dice approach [211]
as follows.
SF (p, q) =
2×
∣∣TXGO (p) ∩ TXGO (q)
∣∣
|TXGO (p) ∪ TXGO (q)|+ |TXGO (p) ∩ TXGO (q)|
(4.12)
where TXGO (u) is the set of GO terms of a given protein u for a given ontology X =
MF,BP,CC, and
∣∣TXGO (u)
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The Czekanowski-Dice’s measure is not convenient for use in the case of GO term sets,
since GO terms may be similar at some level without being identical. This aspect cannot
be captured in the Czekanowski-Dice’s measure which only requires the contribution from
the GO terms exactly matched between the sets of GO terms of these proteins. One can
attempt to avoid this difficulty by incorporating the true path rule in the computation of
the intersection and union of GO term sets for proteins. However, in most cases where
these proteins are annotated by successive GO terms in the GO DAG, this may lead to the
situation where the number of elements in the union of these sets is equal to that of their
intersection plus one, in which case, the functional closeness of these proteins is forced
to converge to 1, independently of biological contents of the GO terms in the GO DAG.
Indeed, let’s consider two proteins p and q annotated respectively, with terms 9 and 10, as
shown in the fictitious hierarchical structure depicted by figure 4.3.
We have T FGO (p) = {9} and T FGO (q) = {10}, and considering an exact match, this will,
in general, lead to SF (p, q) = 0 since T FGO (p) ∩ T FGO (q) is empty. Furthermore, using the
‘true path rule’, we have T FGO (p) = {9, 7, 5, 4, 2, 1, 0} and T FGO (q) = {10, 9, 7, 5, 4, 2, 1, 0}.
Thus T FGO (p) ∩ T FGO (q) = T FGO (p) with 7 elements and T FGO (p) ∪ T FGO (q) = T FGO (q) with
8 elements. Generally, for this case |T FGO (p) | = n, |T FGO (q) | = n + 1 will yield |T FGO (p) ∩
T FGO (q) | = n and |T FGO (p) ∪ T FGO (q) | = n + 1, i.e, the number of elements in the union
of these sets is equal to that of their intersection plus one. This leads to the following
functional similarity measure:





Meaning that for n becoming large SF (p, q) will be forced to converge to 1. This shows
Czekanowski-Dice’s measure yields the functional closeness measure which is independent
of the semantic value of these terms in the GO DAG.
To overcome this problem, we set up a functional similarity between proteins which em-
phasizes semantic similarity between terms in their sets of GO terms considered to be
uniformly distributed. This functional similarity is given by
























































= min{dGO (t, s) : s ∈ TXGO (u)}





= max{SGO (t, s) : s ∈ TXGO (u)} (4.14)
This shows that the functional closeness formula emphasizes the importance of the shared
GO terms by assigning more weight to similarities than differences. Thus, for two proteins
that do not share any similar GO terms the functional closeness value is 0, while for two
proteins sharing exactly the same set of GO terms, the functional closeness value is 1.
Evaluating the GO-Universal Metric
Given two GO terms, a set of GO terms, or two GO annotated proteins from a specific
proteome, equations (4.10) and (4.13) allow computations of semantic similarities between
these GO terms and functional clo eness measures between sets of GO terms or between an-
notated proteins, respectively. To illustrate the approach, we use equations (4.7) and (4.8)
to compute the reachability measure µ (z) and topological information measure τ (z) of GO
terms z in the snapshot of the GO molecular function ontology for the term GO:0004003
(ATP-dependent DNA helicase activity) shown in figure 4.4.
Results are listed in table 4.2 and as we can observe, the higher the level of the term, i.e.,
the further it is from the root node, the higher its topological information, meaning that
children are more informative or more specific than their parent, and for two GO terms in
the same path, the one of the higher level will either be more informative or topologically
identical to that of the lower level.
Using equation (4.10), we calculate the semantic similarity between GO terms in figure 4.4












































Figure 4.4: Snapshot of the term GO:0004003 in the molecular function ontology adapted
from the sub-GO DAG in the AmiGO browser. This is used to illustrate the effectiveness
of the GO-universal metric.
helicase activity (GO:0004003) is closer, or more similar to ATP-dependent helicase activity
(GO:0008026) than to DNA-dependent ATPase activity (GO:0008094) or to DNA helicase
activity (GO:0003678). This is numerically due to the influence of ATP-dependent helicase
activity, reflected by its reachability measure, which is lower than the other terms. It is
topologically caused by the higher number of parents the term ATP-dependent helicase
possesses, some of which are ancestors of DNA ATPase activity and DNA helicase activity,
thus giving the term ATP-dependent helicase a higher biological content property than
DNA-dependent ATPase activity and DNA helicase activity.
This illustration shows the benefit of using our approach, as it provides a scalable and con-
sistent measurement method, in which, the semantic similarity of two terms is completely
determined by their reachability measures and that of their highest informative ancestor,
i.e., the ancestor with the smallest reachability measure. Using the intrinsic topology prop-
erty of the GO DAG, the semantic similarity measure of two terms is in agreement with the
GO consortium vocabulary, in the sense that two terms whose most informative common
ancestor is close to the root have smaller shared topological information compared to those
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Table 4.2: Topological position characteristics µ and Information Content τ of GO terms
extracted from figure 4.4.
GO Id GO Name Level µ (z) τ (z)
GO:0017111 nucleoside-triphosphatase activity 6 0.1861457e-06 1.549674e+01
GO:0004386 helicase activity 7 0.2326821e-07 1.757618e+01
GO:0016887 ATPase activity 7 0.2326821e-07 1.757618e+01
GO:0003678 DNA helicase activity 8 0.5817053e-08 1.896247e+01
GO:0070035 purine NTP-dependent helicase activity 8 0.5817053e-08 1.896247e+01
GO:0042623 ATPase activity, coupled 8 0.1163411e-07 1.826932e+01
GO:0008026 ATP-dependent ATPase activity 9 0.0307619e-16 4.032284e+01
GO:0008094 DNA-dependent ATPase activity 9 0.1057646e-08 2.066722e+01
GO:0004003 ATP-dependent DNA helicase activity 10 0.0026286e-34 8.422920e+01
Table 4.3: Semantic similarities between pair-wise terms in figure 4.4.
GO:0017111 GO:0004386 GO:0016887 GO:0003678 GO:0070035 GO:0042623 GO:0008026 GO:0008094 GO:0004003
GO:0017111 1.00000 0.88169 0.88169 0.81723 0.81723 0.84824 0.38432 0.74982 0.18398
GO:0004386 1.00000 0.88169 0.92689 0.92689 0.84824 0.43586 0.74982 0.20867
GO:0016887 1.00000 0.81723 0.81723 0.96206 0.43586 0.85044 0.20867
GO:0003678 1.00000 0.92689 0.81723 0.43586 0.74982 0.22513
GO:0070035 1.00000 0.81723 0.47027 0.74982 0.22513
GO:0042623 1.00000 0.45308 0.88398 0.21690
GO:0008026 1.00000 0.45308 0.47873
GO:0008094 1.00000 0.24537
GO:0004003 1.00000
As pointed out previously, the biggest limitation of existing approaches based on Resnik’s
algorithm is that they are constrained by the annotation statistics related to the terms.
On the other hand, although Wang’s measure is also based on the intrinsic topology of
the GO DAG, one of the drawbacks of their approach is that it raises the scalability issue
since it requires complete knowledge of the sub-GO DAG of the two terms for which the
semantic similarity is being computed and that of all their common ancestors. However,
it should be noted that GO is expanding and increasing in size, and term relationships are
becoming more and more important. Thus, a semantic similarity measurement approach
should be effective independently of the size of the GO DAG.
Another negative aspect of Wang’s approach is that it essentially relies on the semantic
factors of ’is a’ and ’part of’ relations, which may be user tunable parameters. It is not
clear for which values of these semantic factors the semantic similarity measure yields the
optimal value of biological content of terms. Moreover, these semantic factors make the
similarity value between a given child and its direct parent independent of the number










Chapter 4. Functional Analysis of the MTB Proteome Networks 83
DAG, the semantic similarity between a given term and its child should not only depend
on the number of parents the child term possesses, but also on the number of children
that the parent term possesses. Thus, the semantic similarity must be sensitive to the
number of children of the parent term. The greater the number of children, the smaller
the semantic similarity to each of its children in order to map the idea of ‘the more the
term is used for annotation the lower its semantic value’ in semantic value measures based
on the annotation statistics. This is actually in agreement with human judgement.
4.2.3 Functional Closeness versus Functional Link Score
In order to validate a given semantic similarity measure, an external set of data, such as
sequence similarity, gene expression or protein-protein interactions, correlated with GO
annotations are used. Thus, to validate the GO-universal metric, we used the relation
between functional link confidence scores in the MTB functional network produced in
chapter 3, and their GO annotations downloaded from the Integr8 project of the European
Bioinformatics Institute (EBI).
Using the relationship between link confidence scores in the functional network, and sim-
ilarity scores between their GO annotations as a means of assessing the effectiveness of
our measure, we analyzed the distribution of interactions with respect to these two scores
for all three ontologies, ‘molecular function’, ‘biological process’ and ’cellular component’.
In the computation, link confidence and functional similarity scores, ranging from 0 to 1,
corresponded well. An increase of GO similarity score corresponds to an increase in the
functional link confidence score. Those values close to one indicate high confidence and
those close to zero indicate low confidence.
We analyzed the distribution of these functional interactions with respect to their functional
link confidence and GO similarity scores for each confidence range and for all the three
ontologies using all interaction datasets and results are shown in table 4.4. Note that values
in table 4.4 are ratios of occurrences of functional link and functional similarity scores at
a given confidence level. At this confidence level, the rate r of minimum and maximum
between ratio values of functional link and functional similarity between proteins defines
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Table 4.4: Interaction distribution per confidence type and per ontology for evaluating
our approach in terms of percentage of co-occurrence of functional link (Link Score) and
our similarity scores (GO Sim) at three levels of confidence: low (less than 0.3), medium
(between 0.3 and 0.7) and high (greater than 0.7).
Low confidence Medium confidence High confidence
Name Space Link Score GO Sim Link Score GO Sim Link Score GO Sim
CC 0.09956 0.20391 0.45643 0.18710 0.44401 0.60899
MF 0.04788 0.13826 0.42159 0.30445 0.53053 0.55729
BP 0.05305 0.20719 0.39745 0.25652 0.54950 0.53629
according to the fact that r ≥ 0.5 or r < 0.5.
These results show that there is a positive relationship between link confidence and similar-
ity scores from the medium to high confidence levels for the MF and BP ontologies, indicat-
ing that where link scores and GO similarity measures are greater than 0.3 we are confident
that where proteins are functionally linked, these proteins are also more likely to be anno-
tated to similar GO terms. At a high confidence level, functional link and GO similarity are
related at the level of (0.53053/0.55729)× 100 = 95% and (0.53629/0.54950)× 100 = 98%
for the MF and BP ontologies, respectively. Similarly, at a medium level they are related
at the level of 72% and 65%, respectively. If we consider both medium and high levels,
i.e., we look at the occurrences of functional link and GO similarity between proteins at
a confidence level greater than 0.3, then functional link and GO similarity are correlated
at 91% and 84% for the MF and BP ontologies, respectively, indicating that linked pro-
teins tend to have similar molecular functions and also to be involved in similar biological
processes when we have medium to high confidence in their functional link.
As previously pointed out (in chapter 3), some data (e.g. sequence data) are better for
predicting protein molecular functions, while other data are better for biological process.
Thus, we have conducted the same analysis using only sequence data and results are shown
in Table 4.5. Once again these results indicate that there is a positive relation between
link confidence score and GO closeness at a medium and high confidence level, indicating
that where link score and GO closeness measures are greater than 0.3 we are confident
(confidence or reliability > 0.7) that where proteins are functionally linked, these proteins
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Table 4.5: Interaction distribution per confidence type and per ontology for evaluating our
approach in terms of percentage of co-occurrence of functional links from sequence data
and our GO similarity scores at three levels of confidence: low (less than 0.3), medium
(between 0.3 and 0.7) and high (greater than 0.7).
Low confidence Medium confidence High confidence
Name Space Link Score GO Sim Link Score GO Sim Link Score GO Sim
CC 0.00596 0.16520 0.57302 0.16390 0.42103 0.67089
MF 0.00220 0.02845 0.44469 0.25536 0.55311 0.71618
BP 0.00141 0.08794 0.42060 0.27597 0.57799 0.63609
at (0.55311/0.71618)×100 = 77% and ‘biological process’ at (0.57799/0.63609)×100 = 91%
at high confidence, and 58% and 66% at medium confidence for molecular function and
biological process, respectively. This indicates that homologous proteins tends to have
similar molecular functions and are also involved in similar biological processes from a
medium level of confidence and upwards.
4.3 Annotation Prediction Algorithm
There are several goals that a function prediction algorithm needs to meet in the current ge-
nomic era. These include improvement of annotation quality and genomic coverage, i.e., in-
crease the proportion of genes or gene products in a genome which are annotated [212]. De-
spite the high degree of noise that interaction data from high throughput experiments con-
tain, making them potentially unreliable, uncontested successes have been recorded from
the use of computational approaches to predict functions of uncharacterized data by using
these data. Several approaches have been proposed for predicting protein functions from
functional networks and are mainly classified into two categories, namely global network
topology and local neighborhood based approaches. Global network topology based ap-
proaches use global optimization [213, 214, 215], probabilistic methods [216, 217, 218, 219]
or machine learning [220, 221, 222] to improve the prediction accuracy using the global
structure of the network under consideration. In the case of local neighborhood based ap-
proaches, known as ‘Guilt-by-Association’, ‘Majority Voting’ or ‘Neighbor Counting’ [223],
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The dualism of “Guilt-by-Association” and “Global” prediction approaches for character-
izing a protein has raised a debate separating the Bioinformatics community into divergent
groups with different views concerning how the annotation prediction of proteins labelled
“uncharacterized” should be engineered. On one hand, there are proponents of the “Guilt-
by-Association” strategy, stating that a gene or gene product shares the function of the
most closely related genes of known functions, thus predicting protein functions by ob-
serving the patterns of each protein’s neighborhood. This fraction highlights the inability
of global prediction approaches to provide significant improvement over the simple and
elegant local prediction approach [224]. On the other hand, the advocates of the “Global”
prediction approach argue for a global view of the protein-protein interaction network to
achieve efficient annotation prediction.
From the computational side, the “Guilt-by-Association” prediction approach may be an
excellent and more straightforward approach since the “Global” prediction approach raises
a scalability issue for large datasets which may not be proportional to the prediction im-
provement. However, this straightforward approach may lead to systematic error especially
in the case where the protein under consideration does not share functions with any of its
direct neighbors. This case was depicted in the Yeast Proteome Network and therefore,
Jin and Cho [225] proposed a new approach for dealing with this type of local protein
association behavior by building a “Protein Interaction Network Dictionary (PIND)” in
which the protein target’s function is obtained from characterized proteins whose direct in-
teracting neighbors shared a certain level of similarity with the protein’s target interacting
neighbors. This phenomenon has also been demonstrated by Chua et al. [226, 227], who
showed that in many cases proteins share functional similarity with level-2 neighbors, and
level-2 neighbors have an above average likelihood of sharing functional similarity. They
introduced a functional similarity weight (FS-Weight) method for predicting protein func-
tions from protein interaction data using level-1 and level-2 neighbors. Here, we present
an annotation prediction model which uses direct interacting neighbors combined with sec-
ond level interacting neighbors to achieve efficient trade-off between the scalability issue,
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4.3.1 Guilt-by-Association Approach
The “Guilt-by-Association” approach consists of assigning to a protein the function that
occurs most frequently among its direct interacting partners [223]. Let N be the set of all
proteins in the proteome of the organism under study, T FGO (p) the set of functional GO
terms of a given protein p ∈ N , and FGO = ∪
p∈N
T FGO (p) the set of all functional GO terms
for the proteome of the organism. The frequency ft (p) of the term t ∈ FGO occurring





where Np refers to the set of all direct interacting partners of protein p, and δq is the
q−function indicator given by
δq (t) =
{
1 if the protein q performs the function t
0 otherwise.
In this case, the frequency ft (p) is actually the number of interacting partners of protein
p performing the function t, and serves as a score St (p) of function t for protein p, and the
n most frequent functions, i.e., the n functions with the highest score among interacting
partners of protein p are assigned as the n most likely functions for the protein p.
The score of a functio or functional GO term x for a protein p as set by the Majority
Voting approach does not take into account the number of proteins annotated by the term
x across the entire functional network. Indeed, the more proteins that are annotated by
the term x, the more likely the term is to be found among the interacting partners of
protein p, and also the more likely the protein p may be annotated by the term x. Thus,
if two terms occur at equal frequency among p interacting partners the one annotating
more proteins will obviously have a higher probability of being found in p. However, the
Majority Voting would assign the same score to both functions. A variant of the Majority
Voting, the Chi-Square approach, has been proposed [228] in order to overcome the above
limitation. The Chi-Square approach assigns n largest Chi-Square score functions to the















where ft (p) is defined in equation (4.15), and ǫt(p) = n × πt, the expected number of
partners performing the function t, with πt the fraction of proteins performing function t
among all the proteins and n the total number of proteins in the network.
Another shortcoming of the “Guilt-by-Association” approach beyond the fact that it is
bound to fail in the case where the target protein’s neighbors are also uncharacterized,
is that it does not consider the structure of the entire ontology used to predict these
functions, i.e., it does not take into account the relationships between all annotations
in the ontology under consideration. In most cases, the level at which a term can be
considered to be specific or informative in the annotation hierarchy is fixed, thus leading
to partial coverage of the annotation structure which compromises the prediction analysis
since terms used are not comparable. Furthermore, the “Guilt-by-Association” approach
provides high confident predictions only to proteins sharing significantly similar functions
with their interacting neighbors. This means that these approaches may be misleading and
can yield a very high false positive rate [230]. Taking into account all these observations, we
are predicting the MTB uncharacterized proteins, where possible, by using the functional
organization of level-1 and level-2 interacting partners of the protein under consideration in
the functional network using the MF and BP ontologies of the GO DAG. Throughout this
annotation prediction process, instead of using exact matches only, relationships between
GO terms in the GO DAG structure are considered through the GO term’s semantic
similarity defined in section 4.1. This combination is expected to improve the prediction
quality and the genome coverage.
4.3.2 Protein Function Prediction
We are exploiting the underlying biological principle of the functional network structure
and its dynamics which allow the system to be stable and robust, functioning in a reliable
way. More precisely, we observe the level 1 and 2 neighbors’ function occurrence patterns
to identify the key principles driving the functions imposed to a protein by its neighbors
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on the features of the protein under consideration obtained from its direct and level-2
interacting partners, the optimal strategy, which consists of finding the best use of ‘traces’
of underlying biological principles, is applied to predict more accurately the functions of
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Figure 4.5: Protein function prediction system flow diagram.
As we are using GO terms, namely GO molecular function and biological process terms, to
predict functions of uncharacterized proteins, we must take into account the issue related
to the GO DAG structure in which two terms can be similar without being identical.
Thus, the annotation score of a GO term requiring an exact match as defined previously in
formulas 4.15 and 4.16 is not applicable. We set up a new annotation score using the GO
universal similarity metric for predicting the most likely functions carried out by proteins.
This annotation score can be applied to known proteins or genes in the functional network
to determine the optimal cut-off from which a term can be considered to be a function
of the protein under consideration. This cut-off can also be determined in advance using
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GO Annotation Score and Prediction Algorithm
As pointed out previously, the GO annotation score must take into account the frequency
of GO terms occurring among protein interacting partners and semantic similarity between






SGO (t, s) (4.17)
where TGO (p) =
+∪
q∈Np
TXGO (q) is the multiset or bag (set with possible multiple copies of an
element allowed) of all the GO terms occurring among interacting partners of protein p,
SGO (t, s) is the semantic similarity between two GO terms t and s defined in (4.10), and
TXGO (q) is the set of GO terms of a given protein q for an ontology X = MF or BP . As
in the standard Guilt-by-Association approach, this score estimates the likelihood of the
protein p being annotated by the GO term t.
In fact, the formula in (4.17) depends on number of times a given GO term occurs among
protein neighbors. This scoring formula emphasizes the importance of the GO terms’
frequency of occurrence among the interacting partners of the protein under consideration
and it is clear that this score increases with the frequency of occurrence of a term, since
one can easily show that for a given positive real number ǫ and integers n and k such that




n− 1 + k
This indicates that the scoring formula considers the semantic similarity of GO terms in
the GO DAG and takes into account the GO terms’ frequency of occurrence by increasing
the weight of the terms occurring several times among protein neighbors.
The GO annotation score is computed for every term occurring among protein neighbors.
The threshold is set based on previous knowledge about data or calculated using data on
known protein functions, and GO term exceeding this threshold is assigned as a function
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Evaluation of the Prediction Approach
In order to derive the traces of the underlying biological organization of the MTB functional
network, we make use of this network to determine the optimal parameter cut-off that
provides the best quality of predictions when using the following approaches:
- Guilt-by-Association approach using direct interacting neighbors of the protein target,
with the score computed as in the equation (4.17). This approach is referred to as the
GO-GA approach from now on.
- Guilt-by-Association approach derived from direct interacting neighbors of other proteins.
This is basically the PIND approach, where the potential functions of the protein target are
functions of other proteins whose direct interacting neighbors share significant similarity
with the interacting neighbors of the protein target. In this case, the functional similarity
between the Np and Nq set of neighbors to proteins p and q, respectively, is given by
SF (Tp, Tq) defined in equation (4.13) with Tu =
+∪
v∈Nu
TXGO (v) as the multiset or bag of all
the GO terms occurring among interacting partners of protein u. The potential functions
of the protein target is the multiset comprised of all the functions occurring among proteins
whose interacting neighbors share functional similarity with the protein target’s neighbors.
This is referred to as the GO-PIND approach.
- The method that combines the GO-GA and GO-PIND approaches, referred to as the
GO-GAPIND-1 approach. In this method, the potential functions of the protein target
are obtained by merging the functions occurring among its direct interacting partners and
those of all the proteins whose interacting neighbors share functional similarity with the
protein target’s neighbors.
- Guilt-by-Association approach which uses the level-1 and level-2 neighbors of the pro-
tein target. Investigating the relation between interacting neighbors of a given protein
using network topology, Hua et al. [226, 227] show that in many cases, a protein shares
functional similarity with level-2 neighbors (2 branch-lengths away), which may be used
to provide greater coverage during function inference. However, these level-2 neighbors
yield high false positives and they introduced a Functional Similarity Weight (FS-Weight),
a topological measure from which both level-1 and level-2 neighbors that are more likely
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predictions. They have considered the transitivity of this topological functional similarity
indicating that if a protein p is topologically similar to a protein u, and protein u is topo-
logically similar to protein q, then proteins p and q may show some degree of topological
similarity. Thus, the transitive FS-weight measure is given by
STR (p, q) = max
(
SFS (p, q) ,max
{
SFS (p, u) ∗ SFS (u, q) : u ∈ N+q
})
(4.18)
where SFS (p, q) is the FS-weight score between proteins p and q in the functional network,
defined as


























where navg is the average number of direct neighbors, which is in fact the average degree of
the functional network, given by navg = 2× |L| / |N |, with |N | and |L| being the number
of proteins and functional links, respectively, in the functional network.
Considering the impact of topological similarity weight, the GO annotation score of a term

























the GO semantic similarity score between a term t and a protein v defined






















The formula (4.21) above is adapted from [227] to consider the structure of the GO DAG.
The conventional method only considers the exact match between terms, ignoring the
overall GO DAG structure and relationship between terms. This GO annotation score is
set to zero if Zp = 0, and similarly to the GO-GA approach, this annotation score estimates
the confidence level of annotating the protein p by the term t. This approach is referred
to as the GO-FS approach. Note that the level-2 interacting partners are included in the
computation of the GO annotation score and each occurrence of a protein is considered.
This means that a characterized level-2 interacting partner is included as many times as the
number of different level-1 neighbors it interacts with. Furthermore, level-1 characterized
interacting partners that are level-2 neighbors will contribute more to this score.
- Combining GO-GAPIND-1 and also considering the level-2 interacting proteins is referred
to as the GO-GAPIND-2 approach. In this case, the set of potential functions of the
protein target is obtained from level-1 and level-2 neighbors, and from proteins whose
level-1 neighbors share significant GO-functional similarity with level-1 neighbors of the
protein target. The GO annotation score is computed in the same way as in the GO-GA
approach. Note that a given level-2 interacting partner contributes to the GO-annotation
score as many times as it occurs as a partner of level-1 proteins, and the level-1 that is
also a level-2 partner contributes to the score as a level-1 as well as a level-2 partner.
1. Optimal Parameter Estimation
To determine the optimal GO annotation score threshold from which a GO term may be
more likely to be a protein target’s annotation, we vary this metric from 0.1 to 0.9 and
extract the values that produce the best prediction for each approach described above.
We are considering proteins to be functionally similar if their functional similarity score
from the GO semantic similarity is greater than 0.4, and the same cut-off is used for
semantic similarity between GO terms. This is due to the results displayed in table 4.4
and table 4.5, which show that proteins’ functional similarity are positively related to
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Table 4.6: GO annotation score threshold of each of the five approaches and the corre-
sponding highest precision achieved.
MF ontology BP ontology
Approach Threshold Precision Threshold Precision
GO-GA 0.23 0.623 0.23 0.657
GO-PIND 0.19 0.427 0.28 0.454
GO-GAPIND-1 0.19 0.432 0.23 0.463
GO-FS 0.54 0.475 0.50 0.482
GO-GAPIND-2 0.19 0.583 0.23 0.471





















(a) Precision variation of the five function prediction
approaches for BP ontology.





















(b) Precision variation of the five function prediction
approaches for MF ontology.
Figure 4.6: Precision analysis to determine the optimal GO annotation score cut-off.
For deriving the optimal GO annotation score threshold, we used one of the most impor-
tant measures of the quality of a prediction approach, the precision of prediction, which
measures the proportio of GO terms correctly predicted for a protein among all protein’s





where TP (true positive) represents the number of GO terms correctly predicted, i.e., the
number of observed GO terms which are similar (in terms of GO semantic similarity) as
those predicted, and FP (false positive) is the number of predicted GO terms different
from the actual protein’s GO terms.
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Figure 4.7: Performance analysis of the function prediction approaches for BP ontology.
and the optimal cut-off inferred from each approach with the corresponding highest preci-
sion are given in table 4.6.
2. Performance of Prediction Approaches
Five different protein function prediction approaches described in the section 4.3.2 have
been compared using Receiver Operating Characteristic (ROC) [231, 232] and Precision-
Recall Operating Characteristic (P-ROC) [233] curve analyses. We used leave-one-out
cross-validation to evaluate the the performance of these prediction approaches comput-
ing the false positive (1 − specificity) and true positive rate (sensitivity or recall), given
respectively by





where TN and FN are true negative and false negative, respectively.
The ROC curve plots false positive rate against true positive rate and P-ROC curve plots
precision against recall. In order to compare the performance of these approaches, we
combined their related ROC and P-ROC curves and results are shown in figure 4.7 and
figure 4.8 for the BP and MF ontologies, respectively. With the exception of the GO-GA
approach, which always provides better precision than the others, these results indicate that
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Figure 4.8: Performance analysis of the function prediction approaches for MF ontology.
and the GO-FS approach is better than the others when dealing with the MF ontology.
This means that the GO-GA approach yields the best quality prediction, and as approaches
using level-2 interacting neighbors perform better in terms of ROC curves they can be
used to complement the GO-GA approach to improve genome annotation coverage. For
this purpose, as GO-GAPIND-2 performs better for the BP ontology and GO-FS for the
MF ontology, GO-GAPIND-2 is applied when predicting protein annotations with GO BP
terms and the GO-FS approach is used for prediction of GO MF terms.
4.4 Annotation Prediction of MTB Proteome
We have used results of the ROC and P-ROC curves for the five different protein function
prediction approaches depicted in figures 4.7 and 4.8, and shown that the GO-GA approach
yields better quality annotations, and the GO-GAPIND-2 and GO-FS approaches perform
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Algorithm 1 MTB Protein Function Prediction Algorithm.
Input: Functional Network, GO Term Semantic Similarity, Transitive FS-Weight Mea-
sures, and GO-annotation Score Cut-off
Output: Predicted Functions of Uncharacterized Proteins
1: for each uncharacterized protein p do
2: if p has characterized level-1 neighbors then
3: run GO-GA approach
4: else
5: if p has characterized level-2 neighbors then
6: if ontology := MF then
7: run GO-FS approach
8: else if ontology := BP then
9: run GO-GAPIND-2 approach
10: end if
11: else




We therefore ran the prediction algorithm, which uses the GO-GA approach complemented
by the GO-GAPIND-2 or GO-FS approach, as described in algorithm 1, to predict functions
of uncharacterized proteins in the MTB proteome.
To illustrate the effectiveness of the algorithm used, we apply the algorithm to some pro-
teins with known functions, comparing their true functions to the predicted ones. True
and predicted functions with their GO functional similarity for the selected set of proteins
are shown in table 4.7.
For uncharacterized proteins in the MTB proteome, the functions of 1930 proteins have
been predicted using the BP ontology and 1590 proteins using the MF ontology, repre-
senting, respectively, 83% and 76% of the total number of uncharacterized proteins in the
MTB proteome. This has been achieved using an optimal cut-off of 0.23 for the BP and
MF ontologies under the GO-GA approach, and 0.23 and 0.54 for the BF and MF on-
tologies under the GO-GAPIND-2 and GO-FS approaches, respectively. The prediction
approach used was unable to predict functions for 391 proteins for the BP ontology and
497 proteins for the MF ontology due to the fact that these proteins are clustered with un-
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Table 4.7: True functions of some characterized proteins and their predicted functions using
algorithm 1. The top of the table is for BP and the bottom for MF.
UniProt-Acc Gene-Name True Functions Predicted Functions GO Similarity
GO-ID GO name GO-ID [GO name] Annot. score
P64259 mraY GO:0051301 cell division GO:0051301 0.24148 0.71425
GO:0007049 cell cycle GO:0007049 0.23762
GO:0007047 cell wall organization
GO:0008360 regulation of cell shape
GO:0009252 peptidoglycan biosynthetic
process
P96203 ppsD GO:0008152 metabolic process GO:0008152 0.55361 0.83313
GO:0055114 oxidation reduction 0.48297
GO:0009058 biosynthetic process GO:0009058 0.40118




Q8VJ85 MT3107 GO:0006313 transposition,
DNA-mediated
GO:0006313 0.70999 0.72589
GO:0008033 tRNA processing 0.32890
GO:0006400 tRNA modification 0.27794
O53730 sigK GO:0006355 regulation of transcription,
DNA-dependent
GO:0006355 0.40269 1.00000
GO:0045449 regulation of transcription GO:0045449 0.39618
GO:0006350 transcription GO:0006350 0.36396
GO:0006352 transcription initiation GO:0006352 0.36345






GO:0008152 metabolic process 0.23470
P0A595 glbO GO:0006810 transport GO:0006810 0.48071 1.00000
GO:0015671 oxygen transport GO:0015671 0.48071






P67298 Rv1960c GO:0045449 regulation of transcription GO:0045449 1.00000 1.00000
Q7D9L7 MT0605 GO:0003677 DNA binding GO:0003677 0.52253 0.96406




Q7D638 MT3196 GO:0003824 catalytic activity GO:0003824 0.32775 0.66761
GO:0016787 hydrolase activity GO:0016787 0.33174
GO:0008270 zinc ion binding
GO:0016491 oxidoreductase activity 0.24373
GO:0016829 lyase activity 0.23453
GO:0004803 transposase activity 0.23027
O53461 MT1814 GO:0004519 endonuclease activity GO:0004519 0.54545 1.00000
GO:0003676 nucleic acid binding GO:0003676 0.45455
O06831 fadD12 GO:0003824 catalytic activity GO:0003824 0.54984 0.82872
GO:0016874 ligase activity GO:0016874 0.51981






acting on ester bonds
0.23986
P72047 rfbE GO:0005524 ATP binding GO:0005524 0.34172 1.00000
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are uncharacterized with respect to the BP and MF ontologies, respectively.
4.5 Novel Decryption of the MTB Genome Biology
Available data shows 4195 protein coding genes in the MTB CDC1551 genome, with a total
of 1874 and 2108 proteins which are characterized with respect to the BP and MF ontolo-
gies, respectively. The extensive integration of biological interaction data from different
sources has yielded a functional network containing 4136 proteins. We ran the annotation
prediction algorithm on the MTB network produced to predict, where possible, functions
of proteins labelled ‘uncharacterized’. The resulting dataset consists of a total of 3804 pro-
teins with predicted functions using the GO biological process ontology and 3698 proteins
have predicted functions with respect to the GO molecular function ontology. The analysis
of these data show that out of 3804 proteins with predicted functions with respect to BP
terms, 1343 proteins representing approximately 35% are involved in metabolic processes,
and metabolic process in itself covers about 15% over all processes occurring in the system,
as shown in table 4.8. Note that a protein may be involved in multiple processes, and a
general view of the most common MTB CDC1551 proteome processes is shown in table 4.8.
Further analyses of the GO terms predicted for the uncharacterized proteins were done
using the BLAST2GO program (http://blast2go.bioinfo.cipf.es/start_blast2go),
which uses the Fishers Exact Test for over-representation analysis. Table 4.9 and the charts
in Figure 4.9 show that the majority of newly predicted functions for uncharacterized
proteins include basic cellular processes such as transcription and translation, as well as
lipid metabolism. In terms of level of GO term predicted, for MF, most terms are at level
3, while the BP terms predicted go down to level 9, with the majority at level 6, showing
that some of the newly predicted terms may be reasonably specific.
Of particular importance in the proteome are proteins of the PE/PPE family, which are
generally uncharacterized, but suspected to be involved in antigenic variability. Functions
of a total of 142 out of 147 proteins of this family have been predicted, and some of these
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Table 4.8: Different processes in which MTB proteins are mostly involved.
GO-ID Process GO name Number of Proteins in Weight
GO:0008152 metabolic process 1343 14.96
GO:0055114 oxidation reduction 935 10.42
GO:0006355 regulation of transcription, DNA-dependent 379 4.22
GO:0045449 regulation of transcription 352 3.92
GO:0006810 transport 331 3.69
GO:0006350 transcription 316 3.52
GO:0006412 translation 226 2.52
GO:0006508 proteolysis 215 2.40
GO:0009058 biosynthetic process 209 2.33
GO:0055085 transmembrane transport 162 1.81
GO:0006629 lipid metabolic process 150 1.67
GO:0005975 carbohydrate metabolic process 149 1.66
GO:0006281 DNA repair 144 1.60
GO:0008652 cellular amino acid biosynthetic process 128 1.43
GO:0006310 DNA recombination 109 1.21
GO:0051301 cell division 88 0.98
GO:0007049 cell cycle 83 0.92
GO:0006260 DNA replication 81 0.90
GO:0008610 lipid biosynthetic process 80 0.89
GO:0006807 nitrogen compound metabolic process 68 0.76
GO:0000160 two-component signal transduction system (phosphorelay) 68 0.76
GO:0006811 ion transport 56 0.62
GO:0007059 chromosome segregation 56 0.62
GO:0044237 cellular metabolic process 55 0.61
GO:0006974 response to DNA damage stimulus 54 0.60
GO:0007165 signal transduction 53 0.59
GO:0015074 DNA integration 53 0.59
GO:0006418 tRNA aminoacylation for protein translation 51 0.57
GO:0006313 transposition, DNA-mediated 50 0.56
GO:0006950 response to stress 43 0.48
GO:0007242 intracellular signaling cascade 41 0.46
GO:0045454 cell redox homeostasis 39 0.43
GO:0008033 tRNA processing 39 0.43
GO:0046677 response to antibiotic 38 0.42
GO:0006396 RNA processing 36 0.40
GO:0006352 transcription initiation 36 0.40
GO:0016310 phosphorylation 35 0.39
GO:0007047 cell wall organization 35 0.39
GO:0006468 protein amino acid phosphorylation 34 0.38
GO:0009073 aromatic amino acid family biosynthetic process 33 0.37
GO:0006754 ATP biosynthetic process 33 0.37
GO:0008272 sulfate transport 32 0.36
GO:0009116 nucleoside metabolic process 31 0.35
GO:0006289 nucleotide-excision repair 31 0.35
GO:0006099 tricarboxylic acid cycle 30 0.33
GO:0006164 purine nucleotide biosynthetic process 28 0.31
GO:0006284 base-excision repair 28 0.31
GO:0015031 protein transport 27 0.30
GO:0006541 glutamine metabolic process 27 0.30
GO:0022900 electron transport chain 27 0.30
GO:0009190 cyclic nucleotide biosynthetic process 27 0.30
GO:0009236 cobalamin biosynthetic process 26 0.29
GO:0006725 cellular aromatic compound metabolic process 26 0.29
GO:0009082 branched chain family amino acid biosynthetic process 25 0.28
GO:0009252 peptidoglycan biosynthetic process 25 0.28
GO:0006413 translational initiation 25 0.28
GO:0009273 peptidoglycan-based cell wall biogenesis 24 0.27
GO:0008299 isoprenoid biosynthetic process 24 0.27
GO:0006457 protein folding 24 0.27
GO:0015833 peptide transport 22 0.25
GO:0006779 porphyrin biosynthetic process 22 0.25
GO:0006259 DNA metabolic process 22 0.25
GO:0006520 cellular amino acid metabolic process 22 0.25
GO:0009405 pathogenesis 21 0.23
GO:0006631 fatty acid metabolic process 21 0.23
GO:0015986 ATP synthesis coupled proton transport 21 0.23
GO:0006812 cation transport 20 0.22
GO:0006777 Mo-molybdopterin cofactor biosynthetic process 20 0.22
GO:0008654 phospholipid biosynthetic process 20 0.22
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(a) Biological process ontology.
(b) Molecular function ontology.
(c) Distribution of levels of GO terms predicted.
Figure 4.9: Pie chart showing GO slim functions of hypothetical proteins for MF and BP
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Table 4.9: GO Slim terms (generic GO slim) significantly over-represented in newly pre-
dicted GO set compared to complete set of GO terms.
GO ID GO name P-Value
GO:0043170 macromolecule metabolic process 0.000000
GO:0044238 primary metabolic process 0.000000
GO:0006139 nucleobase, nucleoside, nucleotide and nucleic acid metabolic process 4.42e-12
GO:0008152 metabolic process 7.61e-12
GO:0009987 cellular process 3.90e-11
GO:0019538 protein metabolic process 5.17e-11
GO:0006259 DNA metabolic process 1.17e-10
GO:0003677 DNA binding 1.86e-10
GO:0006350 transcription 4.78e-10
GO:0008233 peptidase activity 8.39e-10
GO:0043283 biopolymer metabolic process 1.94e-08
GO:0044237 cellular metabolic process 1.96e-07
GO:0003676 nucleic acid binding 5.78e-07
GO:0006629 lipid metabolic process 8.71e-06
GO:0016787 hydrolase activity 1.27e-05
GO:0016740 transferase activity 1.45e-05
GO:0050789 regulation of biological process 6.26e-05
GO:0065007 biological regulation 8.98e-05
GO:0005975 carbohydrate metabolic process 0.011421
GO:0006412 translation 0.011646
GO:0009059 macromolecule biosynthetic process 0.011646
GO:0044249 cellular biosynthetic process 0.011646
GO:0007049 cell cycle 0.012909
GO:0004518 nuclease activity 0.014776
GO:0016788 hydrolase activity, acting on ester bonds 0.019536
GO:0003700 transcription factor activity 0.021468
A summary of the main processes in which these proteins are predicted to be involved are
shown in table 4.11. These predictions suggest that most of these proteins may be involved
in proteolysis, metabolic and oxidation reduction processes. This is in general agreement
with the suspicion that these proteins may play an important role in the survival of the
MTB pathogen in the host. We can speculate that they may provide the pathogen the
ability to switch from one metabolic path to another including aerobic and anaerobic,
thus allowing the pathogen to survive within the host in different environments ranging
from high oxygen potential in the lungs to micro-aerobic/anaerobic conditions within the
tuberculous granuloma.
As an illustration of some example annotations, protein MT0787.1, named Ferredoxin-
related protein (UniProt accession Q7D9B4), which is involved in intermediary metabolism
and respiration (figure 4.10(a)) but still uncharacterized with respect to GO biologi-
cal process ontology, is functionally linked to proteins involved in oxidation reduction
(GO:0055114) or sharing similarity at a certain level with this GO term. Thus, it is
likely that Ferredoxin-related protein MT0787.1 is involved in oxidation reduction. For the
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Table 4.10: Predicted functions with their GO annotation scores for some protein members
of the PE/PPE family.
UniProt-Acc Gene-Name GO-ID GO name Annotation score
Q8VKA5 MT1008 GO:0006468 protein amino acid phosphorylation 0.58786
GO:0006508 proteolysis 0.58786
Q7D937 PE7 GO:0008152 metabolic process 0.52573
GO:0055114 oxidation reduction 0.52573
GO:0006508 proteolysis 0.37432
Q8VIW6 MT3756 GO:0006508 proteolysis 1.00000
Q50615 PE PGRS33 GO:0008652 cellular amino acid biosynthetic process 0.35613
GO:0009082 branched chain family amino acid biosynthetic process 0.35428
GO:0055085 transmembrane transport 0.29735
GO:0006810 transport 0.29305
Q8VK65 MT1168 GO:0008152 metabolic process 1.00000
Q8VK71 MT1123 GO:0006508 proteolysis 1.00000
Q8VJ66 MT3247 GO:0006355 regulation of transcription, DNA-dependent 0.33233
GO:0045449 regulation of transcription 0.33233
GO:0006725 cellular aromatic compound metabolic process 0.25052
GO:0055114 oxidation reduction 0.24008
P0A692 ppe30 GO:0008152 metabolic process 0.23468
Q8VKM4 MT0369 GO:0008152 metabolic process 0.83857
GO:0055114 oxidation reduction 0.67714
Q7D568 PE32 GO:0006508 proteolysis 1.00000
O53416 PE PGRS20 GO:0006508 proteolysis 1.00000
Q10892 ppe1 GO:0008152 metabolic process 0.83857
GO:0055114 oxidation reduction 0.67714
Q7DA58 MT0269 GO:0051188 cofactor biosynthetic process 0.26862
GO:0006541 glutamine metabolic process 0.24554
GO:0009236 cobalamin biosynthetic process 0.23250
Q7D4P4 MT3987 GO:0051301 cell division 0.31231
GO:0007059 chromosome segregation 0.31231
GO:0007049 cell cycle 0.31231
GO:0045449 regulation of transcription 0.27694
GO:0006355 regulation of transcription, DNA-dependent 0.27694
Q10778 ppe21 GO:0008152 metabolic process 0.49715
GO:0006629 lipid metabolic process 0.40134
GO:0006631 fatty acid metabolic process 0.29640
GO:0008654 phospholipid biosynthetic process 0.29065
Q7D8N0 MT1233 GO:0006508 proteolysis 1.00000
O86338 PE6 GO:0006508 proteolysis 1.00000
Q7D7Y7 MT1839 GO:0008152 metabolic process 0.28426
Q7D7Y8 MT1838 GO:0055114 oxidation reduction 1.00000
Q7D8Q2 PPE17 GO:0045449 regulation of transcription 0.55388
GO:0006355 regulation of transcription, DNA-dependent 0.55388
GO:0006350 transcription 0.33333
P42611 ppe10 GO:0008152 metabolic process 0.24834
Q8VJK7 MT2422 GO:0008152 metabolic process 0.23520
O06246 ppe59 GO:0008152 metabolic process 0.24834
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UniProt-Acc Gene-Name GO-ID GO name GO-score
Q7D5G7 PE31 GO:0006629 lipid metabolic process 0.50899
GO:0008152 metabolic process 0.48975
GO:0006508 proteolysis 0.39356
Q8VIY9 MT3615.3 GO:0008152 metabolic process 0.68716
GO:0006508 proteolysis 0.37432
Q7D8W7 MT1096.1 GO:0006508 proteolysis 1.00000
Q8VIY0 MT3663 GO:0008152 metabolic process 0.24615
Q7D4N3 PE36 GO:0051301 cell division 0.61929
GO:0007049 cell cycle 0.61929
GO:0007059 chromosome segregation 0.61929
Q8VJ87 MT3105 GO:0051301 cell division 0.61929
GO:0007049 cell cycle 0.61929
GO:0007059 chromosome segregation 0.61929
Q7D7Y6 MT1840 GO:0006508 proteolysis 1.00000
Q7D7X9 PPE29 GO:0008152 metabolic process 0.26232
Q7D974 MT0854.1 GO:0008152 metabolic process 0.57379
GO:0009058 biosynthetic process 0.55642
GO:0055114 oxidation reduction 0.48769
Q7D9B9 MT0779 GO:0008152 metabolic process 0.51728
GO:0006313 transposition, DNA-mediated 0.51728
P31500 ppe46 GO:0008610 lipid biosynthetic process 0.53351
GO:0006313 transposition, DNA-mediated 0.53351
Q8VIZ0 MT3612.1 GO:0006508 proteolysis 0.38380
GO:0006313 transposition, DNA-mediated 0.37483
GO:0008152 metabolic process 0.36535
Q11031 ppe19 GO:0005975 carbohydrate metabolic process 0.45012
GO:0008610 lipid biosynthetic process 0.43301
GO:0006013 mannose metabolic process 0.42628
GO:0006508 proteolysis 0.33941
Q8VJW5 MT1836 GO:0055114 oxidation reduction 1.00000
Q7D8M9 PPE18 GO:0055114 oxidation reduction 1.00000
Q8VIX6 MT3701 GO:0006508 proteolysis 0.47303
GO:0019538 protein metabolic process 0.47303
GO:0006289 nucleotide-excision repair 0.37837
Q10637 PE PGRS24 GO:0006508 proteolysis 1.00000
Q7DAC9 PE4 GO:0006508 proteolysis 1.00000
Q10540 ppe13 GO:0008152 metabolic process 0.24834
Q8VKC5 MT0894 GO:0008152 metabolic process 0.52573
GO:0055114 oxidation reduction 0.52573
GO:0006508 proteolysis 0.37432




















(a) Direct interacting partners of protein
‘MT0787.1’ (Intermediary metabolism and respira-





























































































(b) Direct interacting partners of protein ‘MT3181’

























































































(c) Direct interacting partners of protein ‘M2919’
(PE/PPE protein) predicted to be involved metabolic
process.
Figure 4.10: Illustration of Annotation inference. Protein target is in blue at the center,
proteins in green are those sharing GO similarity at a certain level and those in pink are
those with no similar term with the one predicted for the protein target. Proteins in gray
are uncharacterized with respect to BP ontology.
specifically to the PE family proteins, all its annotated interacting partners are involved in
proteolysis process (GO:0006508) or share similarity at a certain level with GO:0006508.
In this case, the most probable biological process in which the protein MT3181 may be
involved is proteolysis. Similarly, the protein MT2919 (Q8VJC0) in figure 4.10(c) belongs
to PE/PPE/PGRS family protein, more precisely the PE-PGRS family protein, and most
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Table 4.11: Different processes in which PE-PPE proteins are mostly involved.
GO-ID Process GO name Number of Proteins Weight
GO:0006508 proteolysis 68 21.3
GO:0008152 metabolic process 51 16.0
GO:0055114 oxidation reduction 24 7.5
GO:0006355 regulation of transcription, DNA-dependent 9 2.82
GO:0045449 regulation of transcription 9 2.82
GO:0008652 cellular amino acid biosynthetic process 8 2.51
GO:0006810 transport 8 2.51
GO:0005975 carbohydrate metabolic process 7 2.19
GO:0006629 lipid metabolic process 5 1.57
GO:0009058 biosynthetic process 5 1.57
GO:0055085 transmembrane transport 5 1.57
GO:0051301 cell division 5 1.57
GO:0007059 chromosome segregation 5 1.57
GO:0007049 cell cycle 5 1.57
GO:0007242 intracellular signaling cascade 4 1.25
GO:0008610 lipid biosynthetic process 4 1.25
GO:0006313 transposition, DNA-mediated 4 1.25
share similarity at a certain level with GO:0008152. Thus, its predicted GO biological
process is metabolic process.
4.6 Summary
In this chapter we perform a functional analysis of the MTB network through protein
function prediction using a local neighborhood (level-1 and level-2) based approach. The
key idea driving the choice of the approach used to predict protein function is the underlying
biological principle of the MTB functional network structure, allowing the system to be
stable and robust, functioning in a reliable way. We predicted functions of a large number
of uncharacterized proteins in MTB CDC1551 using GO biological process and molecular
function terms, using the GO-universal similarity metric to compare these GO terms. This
has yielded additional information about the biology of MTB CDC1551 with 3804, and
3698 proteins with predicted functions using the GO biological process and molecular
function ontologies, representing approximately 90.7% and 88.2% of the MTB proteome,
respectively. Further analysis of these predictions has revealed that most of MTB proteins











Structural Analysis of the MTB
Proteome Networks
The biological analysis of organisms has evolved from a one-by-one gene approach to the
whole genome focus, providing the opportunity to look at genes within their context in
a cell and achieve a global view. For the organism under study, namely Mycobacterium
tuberculosis (MTB), the contribution of knowledge discovered from both primary data,
such as genomic sequences and functional data from high-throughput experiments has led
to the construction of a protein-protein functional network. Such a network allows the
organism’s proteome to be handled in a global fashion in order to unravel the underlying
principles of its biological properties for the purpose of building a predictive disease model
and identifying novel therapeutic drug targets for disease. The network obtained represents
all protein pair interactions derived from different biological data sources. Thus, after
performing the functional analysis of the network (chapter 4), the next step is to explore
(1) the interplay between each protein pair in the network and their contribution to disease,
and (2) how they reliably function for the survival and fitness of the organism on the basis
of the network topology. This may help identify proteins which enable the organism to
efficiently carry out its high goal in the host.
In this chapter, we perform extensive computations to detect the key principles driving
the biological organization of the organism, and decorticate the system to identify proteins
that are potentially indispensable for the survival and viability of the organism, referred to
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as supplementary proteins. This categorization can provide clues toward finding effective
drug targets. Essential proteins are ultimate candidates [234], and could possibly lead to
new anti-tuberculosis compounds with novel mechanisms of action. Of particular interest in
these rationale target-based strategies, are proteins identified by previous research projects
to be unique to Mycobacterium tuberculosis or to pathogens including protein members of
the Pro-Glu and Pro-Pro-Glu (PE/PPE) and Polymorphic GC-Rich Sequence (PE-PGRS)
families. They have been suspected to play a role in the virulence or immunogenicity of
tuberculosis [235, 236] by altering the way the host responds to the infection. They may
have a particular role in helping the organism evade the host immune response and in
latency, and are thus likely to be important for the specific lifestyle of the organism. Along
with them, a significant proportion of proteins labelled hypothetical and uncharacterized
in protein sequence databases are unique to these pathogens.
In the following section, we describe several measures of network centrality that are later
applied to the MTB functional network to identify structurally important proteins in the
network. Thereafter, we perform biological analysis of these proteins to determine which
of those may be essential for the organism based on the topology of the network. Finally,
we map suspected virulence genes and hypothetical proteins of interest onto the functional
network to identify the neighborhood of those proteins effectively playing a key role within
the bacterial infection and disease-causing process.
5.1 Topological Network Centrality Measures
In order to understand the biological organization of the organism from its protein func-
tional network and use this as a means to develop appropriate treatment strategies for the
disease, complete knowledge of the network structure and the contribution of each protein
to the system’s biological processes are required. This section describes network measures
that are used to numerically characterize the importance of proteins in the system, and
their contribution to the functioning of the system, thus assessing the topological signifi-
cance of these proteins within the network and quantifying the structural properties of the
functional network produced. These measures include degree or connectivity, betweenness,
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which are potentially crucial to the functioning of the system, thus contributing to the
survival of the organism.
Throughout this section, we denote by G (N ,L) the MTB functional network, with N the
set of interacting proteins and L the set of functional interactions or connections between
proteins, represented by the adjacency matrixA, an n×n symmetric matrix, where n = |N |
is the number of proteins in the network and whose components apq are defined as follows:
apq =
{
1 if the protein p is functionally linked to the protein q,
0 otherwise.
Here, proteins in N are numbered from 1 to n, and a protein p is represented by its
position number denoted by p. The adjacency matrix A is symmetric since if the protein p
is functionally linked to the protein q, then clearly the protein q is also functionally linked
to the protein p. Note that a given protein p is not functionally linked or connected to
itself, i.e., app = 0.
π (p, q) denotes the distance between proteins p and q or the length of the shortest path
from a protein p to a protein q, i.e., the number of links in the shortest path between p
and q for an unweighted graph; the shortest path between proteins being the path with the
minimum number of edges connecting these proteins. If no path exists between proteins p
and q then π (p, q) = ∞.
5.1.1 Degree and Betweenness Centrality Metrics
The degree or connectivity of a protein p is the number of links connected to it, i.e., the




δ (p, q) (5.1)
where
δ (p, q) =
{
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In terms of the adjacency matrix A, the degree of a protein p is simply the sum of compo-
nents in the row or the column corresponding to the protein p, given by
n∑
q=1




In fact, the degree or connectivity of a protein provides an indicator of its influence on the
biological processes occurring in the organism meaning that a protein with more functional
connections tends to contribute to several processes, and may thus be a key protein in the
functioning of the system.
The betweenness centrality of a protein p in a functional network is a metric that expresses
the influence of p relative to other proteins within the network. It is based on the proportion
of shortest paths between other proteins passing through the protein target [238] and shows
the importance of a protein for the transmission of information between other proteins
in the network. This metric provides an indication of the number of pair-wise proteins
connected indirectly by the protein target through their direct functional connections.







where σst (p) is the number of shortest paths from protein s to protein t passing through
p, σst the number of shortest paths from s to t in the functional network, and Np =
{(s, t) ∈ N ×N : s 6= p 6= t and s 6= t}.
The normalized betweenness of a protein p, lying between 0 and 1 is given by
B (p) =
1






Thus, proteins with high betweenness are expected to ensure the connectivity between pro-
teins in the functional network and are able to bridge or disconnect connected components.
As the MTB functional network generated has a scale free property, such proteins are hubs,
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of proteins with low degree, thus integrating all proteins in a given connected component
into a unified complex system. These proteins are of utmost importance for the integrity
and the robustness of the system and are responsible for the small world property since
connections between proteins are relatively short via these hubs.
5.1.2 Closeness and Confidence Measures of a Protein
The status, S (p), of a protein p in a connected network is the average distance to all other
proteins, i.e, the ratio of the sum of π (p, q) for all proteins q in the network to the total






π (p, q) (5.5)
The closeness measure, Cs (p), of a protein p is the inverse [237] of its status and reflects
the ability of the protein to access information via other proteins and to propagate infor-
mation through the network. As the MTB functional network is not completely connected,
this closeness measure is calculated for each connected part separately and normalized to
(nc − 1) / (|Lc| − 1) [239], where nc is the number of nodes in the connected part of the
graph containing the node and |Lc| its size, i.e., the number of functional links in the con-
nected component. This is to make the scale uniform for comparison. Thus, the closeness
measure of a protein p is given by
Cs (p) =
|Lc| − 1
(nc − 1)× Sr (p)
(5.6)
where Sr (p) is the status of p relative to its connected component.
The closeness measure is high for a protein that is central since it has a shorter distance
on average to other proteins. We define the center of gravity Gc of the network as the set
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The eccentricity, E (p), of a protein p in a given connected graph is the maximum length
of shortest paths from protein p to all other proteins in the network, i.e.,
E (p) = max {π (p, q) : q ∈ N} (5.8)
In the context of the MTB functional network, the eccentricity E (p) of a protein p is com-
puted according to its connected component and we consider the inverse of the eccentricity
obtained, and normalize it, as done previously. The measure is referred to as the confidence
Ce (p) of protein p, expressing its capability to quickly communicate with other proteins in
the network, and given by:
Ce (p) =
|Lc| − 1
(nc − 1)×Er (p)
(5.9)
where Er (p) is the eccentricity of p relative to its connected component.
The higher the confidence of a protein in the functional network, the quicker it communi-
cates with other proteins in the network. We define the reference center Rc of the network









5.1.3 Eigenvector Centrality Metric
The degree or connectivity metric provides a simple number of functional connections
without weighting them. The eigenvector metric considers the importance or weight of
these functional connections [237]. In fact, functional connections are not equally important
and functional connections to more influential proteins will impact more on the contribution
of the protein than functional connections to less influential proteins. Thus, the eigenvector
centrality metric assigns a relative weight to all proteins in the network based on the fact
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Let cp be the numerical value representing the contribution of the protein p to the func-
tioning of the system. cp is then proportional to the contributions of its neighbors to the
system. This means that
n∑
q=1
apqcq = λcp (5.11)
where λ is constant for every protein p in the functional network. In matrix form, this can
be written as follows:
Ac = λc (5.12)
where c = (c1, . . . , cn)
T , the transpose of the vector (c1, . . . , cn) , which defines a vector of
contributions of each protein. The vector c is an eigenvector of the adjacency matrix A
associated with eigenvalue λ. It is known that λ is the largest eigenvalue of the adjacency
matrix and c is its non-negative corresponding eigenvector [237, 240].
In this metric, the contribution of a given protein to the functioning of the system de-
pends not only on the number of its interacting neighbors but also on the quality of these
neighbors. Proteins with a high number of functional interactions are important, but a
protein with a small number of high-quality functional connections may contribute more
to the survival of the organism than one with a large number of low-quality functional
connections.
5.2 Topological Analysis of the MTB Functional Net-
work
The robustness of the system is observed through its stability, expressed by its ability to
remain non vulnerable under changing environmental conditions or stressful perturbations
due to a protein knock-out or attack. Topologically, this can be seen as the potential
connectivity of the network under a protein disruption. The disruption can be random,
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assumed to be essential for the system functioning is disrupted, referred to as targeted
attack.
5.2.1 Assessing High-Degree Proteins
We have previously seen that the MTB functional network exhibits a ‘scale-free’ property.
As such, it is expected to be vulnerable against targeted attack and robust against random
attack. In order to assess the topological essentiality of MTB proteins, we classify them in
two categories, namely proteins with a high degree referred to as degree-based hubs and
those able to disconnect the functional network, known as structural hubs. A protein is
considered to be a degree based hub if its degree is above the average degree of proteins in
the MTB functional network, which is 28. We first observe the changes in the number of
connected components and in the number of proteins in the largest connected component
by repeatedly (1) knocking out randomly selected proteins referred to as random attacks,
(2) disrupting the highest degree proteins, referred to as degree-based hub attack, and (3)
removing proteins able to disconnect the network, referred to as structural hub attack. To
simulate an attack, a given number of proteins is chosen for each category and the process
is repeated 1000 times by randomly choosing proteins and computing the average number
of the resulting components and the number of proteins in the largest component. Results
are shown in figure 5.1 and indicate that the MTB functional network is vulnerable to
targeted structural hub attacks.
Indeed, the more structural hubs that are removed the higher the number of connected com-
ponents. This means that the more structural hubs that are removed, the more the network
is disintegrated, whereas the disruption of randomly selected proteins, or of degree-based
hubs, does not perturb the general structure of the network. This means that structural
hub proteins play an essential role in the network integrity. Therefore, knocking out these
proteins may disturb the functioning of the system and negatively impact on the ability of
this pathogenic bacterium to carry out its higher goal in the host.
We have also analyzed the network connectivity by observing the size of the largest con-
nected component. Figure 5.1(b) shows that the size of the largest component rapidly
decreases when structural hubs are disrupted. This indicates that the network is disin-
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(a) Variations in the number of connected compo-
nents.
































(b) Variations in the number of proteins in the
largest connected component.
Figure 5.1: Assessing network vulnerability under random and targeted attacks.
structural hubs in maintaining the network connectivity.




















Figure 5.2: Analyzing the variations in the betweenness metric in terms of protein category.
5.2.2 Assessing Central Proteins
The betweenness metric represents a significant indicator of network essentiality [161].
Proteins with high betweenness are essential to the functioning of the system, serving as
bridges for communication between several other proteins in the network. A protein with
high confidence or closeness will be more important because it has a smaller path length to
reach all other proteins in the network, allowing the system to quickly exhibit appropriate
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(a) Variations in the closeness measure.
























(b) Variations in the confidence metric.
Figure 5.3: Assessing the variations in closeness and confidence centrality measures in
terms of protein category.
functional importance of proteins obtained by ordering proteins by betweenness, closeness
and confidence measures of hubs, and observing the cumulative proportion for every 10
proteins. These results reveal that proteins with high degrees and located in the center
of the network may reach all the nodes in a given connected component with fewer steps
compared to the structural hubs. These results combined with those in figures 5.3 suggest
that a protein, which is structural hub and has a high degree, is important for the survival
of the bacterial pathogen. These proteins are considered to be potential drug targets and
can be used to enhance the discovery process of new antibiotics with novel mechanisms of
action to treat the disease.
5.3 Important Proteins in the MTB Functional Net-
work
In this section, we are investigating the biological significance of proteins found to be struc-
turally important in the functional network. Specifically, we are looking at the functions
that are carried out by proteins found in the center of gravity Gc with high betweenness
and connected to some influential proteins at certain levels, i.e., proteins with eigenvector
centrality greater than 10−5. We are also interested in the biological processes in which
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the identification of proteins that are potentially essential for the survival of the bacterial
pathogen. These proteins are considered to be potential drug targets, as they correspond
to bottlenecks in the MTB functional network and are therefore expected to be key compo-
nents of the organism’s cellular processes. Bottleneck proteins are proteins responsible for
several indirect functional connections between other proteins in the functional network.
Note that the confidence metric is not used since there is no discerning difference between
eccentricity distribution of hubs and non hubs. Thus, this metric could not be used to
distinguish essential proteins from non-essential proteins.
As the average shortest path length is 3.678, a protein in the functional network is said to
belong to the gravity center if its closeness metric, as defined in equation (5.6) is greater
than 1/3.678, which is approximately 0.27189. In the case of the betweenness measure,
a protein with betweenness above the total number of shortest paths expected to pass
through the protein in the functional network is of interest, and this number is about
15212.21. Thus, we identified a set of 881 proteins, which constitutes a set of important
proteins and thus potential drug targets within the bacterial pathogen.
Furthermore, we use function prediction of uncharacterized proteins performed in sec-
tion 4.4 of chapter 4, leaving out proteins which remained uncharacterized to refine the
results. Before running the prediction annotation algorithm, 292 proteins out of the 881
were uncharacterized with respect to GO biological process terms. After deploying the
prediction annotation algorithm, functions of 245 proteins were predicted and 47 remain
uncharacterized. The resulting dataset consists of a target set of 834 proteins and the
analysis performed on this set is shown in table 5.1, and indicates that of the 834 target
proteins, 347 are involved in metabolic processes, 226 in oxidation reduction processes, and
a significant number of target proteins are involved in regulation, transport, proteolysis,
etc. Note that a given protein may be involved in multiple processes.
Further functional analysis was performed using the small group of high level functional
classes assigned to all the proteins. The distribution of these potential drug targets per
functional class is shown in figure 5.4. These results indicate that most of the protein
candidate drug targets are involved in intermediary metabolism, followed by a significant
proportion of proteins in the unknown class and those belonging to the cell wall and cell
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Table 5.1: Different processes in which MTB potential drug targets are mostly involved.
GO-ID Process GO name Number of Proteins in Weight
GO:0008152 metabolic process 347 15.78
GO:0055114 oxidation reduction 226 10.28
GO:0006355 regulation of transcription, DNA-dependent 92 4.18
GO:0045449 regulation of transcription 86 3.91
GO:0006350 transcription 85 3.87
GO:0006810 transport 71 3.23
GO:0009058 biosynthetic process 55 2.50
GO:0006412 translation 47 2.14
GO:0006508 proteolysis 43 1.96
GO:0006629 lipid metabolic process 36 1.64
GO:0005975 carbohydrate metabolic process 34 1.55
GO:0055085 transmembrane transport 33 1.50
GO:0008652 cellular amino acid biosynthetic process 33 1.50
GO:0006281 DNA repair 30 1.36
GO:0051301 cell division 29 1.32
GO:0007049 cell cycle 27 1.23
GO:0000160 two-component signal transduction system (phosphorelay) 24 1.09
GO:0044237 cellular metabolic process 23 1.05
GO:0006974 response to DNA damage stimulus 23 1.05
GO:0007059 chromosome segregation 20 0.91
GO:0006418 tRNA aminoacylation for protein translation 18 0.82
GO:0006260 DNA replication 18 0.82
GO:0008610 lipid biosynthetic process 17 0.77
GO:0006811 ion transport 16 0.73
GO:0046677 response to antibiotic 15 0.68
GO:0006310 DNA recombination 14 0.64
GO:0006807 nitrogen compound metabolic process 13 0.59
GO:0006950 response to stress 12 0.55
GO:0006096 glycolysis 10 0.45
GO:0007047 cell wall organization 10 0.45
GO:0016310 phosphorylation 10 0.45
GO:0006164 purine nucleotide biosynthetic pr cess 10 0.45
GO:0006541 glutamine metabolic process 10 0.45
GO:0006099 tricarboxylic acid cycle 9 0.41
GO:0007242 intracellular signaling cascade 9 0.41
GO:0045454 cell redox homeostasis 9 0.41
GO:0006221 pyrimidine nucleotide biosynthetic process 9 0.41
GO:0015833 peptide transport 9 0.41
GO:0015074 DNA integration 9 0.41
GO:0007165 signal transduction 9 0.41
GO:0006396 RNA processing 8 0.36
GO:0006313 transposition, DNA-mediated 8 0.36
GO:0006468 protein amino acid phosphorylation 8 0.36
GO:0006520 cellular amino acid metabolic process 8 0.36
GO:0009432 SOS response 8 0.36
GO:0006730 one-carbon metabolic process 8 0.36
GO:0006457 protein folding 8 0.36
GO:0009116 nucleoside metabolic process 7 0.32
GO:0009082 branched chain family amino acid biosynthetic process 7 0.32
GO:0009097 isoleucine biosynthetic process 7 0.32
GO:0009252 peptidoglycan biosynthetic process 7 0.32
GO:0006633 fatty acid biosynthetic process 7 0.32
GO:0006754 ATP biosynthetic process 7 0.32
GO:0006352 transcription initiation 7 0.32
GO:0008272 sulfate transport 7 0.32
GO:0006779 porphyrin biosynthetic process 7 0.32
GO:0006413 translational initiation 6 0.27
GO:0009405 pathogenesis 6 0.27
GO:0006526 arginine biosynthetic process 6 0.27
GO:0008654 phospholipid biosynthetic process 6 0.27
GO:0015986 ATP synthesis coupled proton transport 6 0.27
GO:0008360 regulation of cell shape 6 0.27
GO:0006289 nucleotide-excision repair 6 0.27
GO:0009190 cyclic nucleotide biosynthetic process 6 0.27
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Figure 5.4: Distribution of candidate drug targets per functional class.
Table 5.2: Repartition per class of potential drug target proteins, considering those which
are central and those considered to be more influential.
Functional Class Proteins Drug targets Central Targets Influential Targets
1 virulence, detoxification, adaptation 176 31 2 1
2 lipid metabolism 230 75 35 28
3 information pathways 245 85 21 -
4 cell wall and cell processes 618 112 52 5
5 insertion seqs and phages 82 10 - -
6 PE/PPE 147 69 2 -
7 intermediary metabolism and respiration 884 262 93 70
8 unknown 1637 169 24 10
9 regulatory proteins 176 68 12 -
Total 4195 881 241 114
which are either more central or more influential in the system and classified them per
functional class. Results are shown in figure 5.5 and figure 5.6, and in table 5.2. These
results show that most of the potential drug targets that are central to the functioning of
the system, ensuring quick communication between proteins in the system, are involved in
intermediary metabolism and respiration, cell wall and cell processes, and lipid metabolism.
Those involved in intermediary metabolism and respiration, as well as lipid metabolism,
are connected to proteins participating in several processes, thus playing key roles in the
system.
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Figure 5.5: Distribution of more influential drug targets per functional class.
inter
ays
Figure 5.6: Distribution of more central drug targets per functional class.
with different network properties. Table 5.3 shows that the hub, high degree (50-99) and
high betweenness proteins, as well as the predicted drug target list are significantly over-
represented by PE/PPE proteins. Lipid metabolism proteins also feature highly in most of
these lists, and regulatory proteins in some of these. One would expect regulatory proteins
to be reasonably well connected as they are likely to have an effect on multiple genes.
Interestingly, the high closeness measure proteins tend to be from the unknown class. The
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Table 5.3: Summary of over-representation analysis of functional classes for different pro-
tein sets based on network properties.
Protein set Over-represented function P-value Adjusted P-value
Hubs PE/PPE 2.10576e-05 1.89518e-04
Degree >= 100 lipid metabolism 4.37537e-12 1.96891e-11
Degree 50− 99 intermediary metabolism and respiration 1.06668e-25 9.60013e-25
lipid metabolism 2.33426e-08 7.00278e-08
information pathways 0.0209259 0.0470832
regulatory proteins 1.91556e-52 8.62003e-52
PE/PPE 8.196e-115 7.3764e-114
Degree 10− 49 lipid metabolism 0.00358115 0.0080576
intermediary metabolism and respiration 1.33874e-58 1.20487e-57
information pathways 2.6561e-10 7.96829e-10
virulence, detoxification, adaptation 4.90211e-11 2.20595e-10
Degree < 10 unknown 4.98171e-180 4.48354e-179
cell wall and cell processes 4.47945e-04 1.78646e-03
insertion seqs and phages 5.95487e-04 1.78646e-03
Betweenness > 15 000 lipid metabolism 2.03723e-04 3.66702e-04
intermediary metabolism and respiration 5.99428e-08 1.79828e-07
information pathways 1.54837e-06 3.48383e-06
regulatory proteins 3.51658e-08 1.58246e-07
PE/PPE 4.48875e-11 4.03987e-10
Closeness > 0.5 unknown 2.58864e-14 2.32978e-13
Eigenvector > 0.08 lipid metabolism 1.5511e-12 6.97994e-12
intermediary metabolism and respiration 2.85447e-31 2.56902e-30
Drug Target lipid metabolism 2.68651e-05 4.83571e-5
intermediary metabolism and respiration 2.12524e-11 9.56358e-11
information pathways 4.13904e-07 9.31285e-07
regulatory proteins 6.36758e-08 1.91027e-07
PE/PPE 1.53973e-12 1.38576e-11
Table 5.4: Summary of network properties of protein sets from the total proteome in the
network, those required for normal growth and those required for survival during infection.
Metric Total Growth Survival
Average Eigenvector 0.003403 0.004342 0.003486
Average Betweenness 10792.87 16108.18 11487.32
Average Closeness 0.28629 0.298827 0.287806
Average Degree 28.082 36.95911 33.17778
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Sassetti and colleagues [241, 242] published two lists of genes from MTB H37Rv that have
been shown to be involved in either normal growth or for survival during infection. These
genes were mapped to CDC1551 identifiers using the orthologues file from the EBI Integr8
project and the network properties for these genes are summarised in table 5.4.
The set of genes required for normal mycobacterial growth tend to have higher average
Eigenvector, betweenness, closeness and degree values than the overall proteome. For
those required for infection, these values are generally higher than the total average, but
not as high as for the growth set. Of the 881 drug target proteins, 197 are on the list of
proteins required for growth, and 38 are on the list of proteins required for survival during
infection. This enhances their suitability as drug targets, since they have been shown
experimentally to be required by the organism.
5.4 Summary
In this chapter, we perform a structural analysis of the MTB CDC1551 functional network,
which has enabled potential drug target identification within the bacterial pathogen. This
analysis shows that 881 proteins out of 4136 found in the network were predicted to be
essential for the functioning of the system and may therefore contribute to the survival
of the bacterial pathogen in the host. After removing proteins which remained uncharac-
terized after applying the protein function prediction algorithm, 834 potentially essential
proteins were left. These proteins can form a target list for new drug development and for
screening available drugs for the treatment of tuberculosis. However, they would need to
go through a number of other screens first in terms of identifying related proteins in the












Tuberculosis (TB) remains a public health challenge today, claiming millions of lives and
new cases every year. The existing antibiotics, together with enhanced provision of ser-
vices in recent years, such as Direct Observed Treatment (DOT), are of immense value in
controlling the disease. However, these drugs have several shortcomings, the most impor-
tant being the emergence of drug resistance, making even the front-line drugs ineffective.
In addition, the deadly interaction between TB and HIV/AIDS is threatening to compro-
mise gains in TB control, leading to further challenges for anti-tubercular drug discovery.
This clearly indicates that the goal of eradicating TB in the coming years depends on the
development of new diagnostics, drugs and vaccines.
The identification of drug targets has traditionally been achieved using the complete knowl-
edge of individual proteins and their well characterized functions. Unfortunately, this
strategy has failed to deliver a sufficient molecular diversity of drugs in order to overcome
this public health challenge. In this work, we have integrated biological data from mul-
tiple sources into a single network of protein functional interactions for the analysis of
Mycobacterium tuberculosis (MTB) uncharacterized genes. This provides a systems view
of the whole organism for the identification of potential drug targets within the bacterial
pathogen. In order to integrate the data and use it for function prediction, we developed
new scoring methods for data from microarray experiments and from protein sequence and
signature data, and also developed a novel GO semantic similarity metric. All the data and
results have been stored in a MySQL database and made accessible via a web interface,
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links to KEGG, GO, etc.
We identified potential drug targets through functional and structural analyses of the
MTB functional network produced. Functional analysis was performed through function
prediction, where possible, of uncharacterized proteins, many of which are specific to the
mycobacteria and suspected to play a role in the virulence of MTB. The structure of the
network has been analyzed using network centrality measures to identify proteins which
maintain the MTB system’s stability and robustness, thus helping the bacterial pathogen
to survive and achieve its high goal within the host. This has yielded a new predicted MTB
biology in which 3804 proteins out of 4195 have predicted annotations with GO biological
process terms, of which 834 were identified as potential drug targets within MTB. 3698
proteins have predicted annotations with GO molecular function terms.
This approach may answer critical questions that are often difficult to address experimen-
tally and provide a rational drug target identification mechanism at the molecular level
for the disease. It also helps us to better understand the biology of the organism as a
whole system and may serve to narrow down the scale of further high throughput target
screening. Furthermore, this may contribute to the process of developing new antibiotics
with novel mechanisms of action for better treatment of the disease by saving time and
reducing the cost.
There is room for further research to complement and extend the work presented in this
thesis. These include the following aspects:
1. The study of the system’s behavior under changing environmental conditions. This
essentially consists of identifying individual components of the system, which can be used
to predict the probable response of the system to perturbation. For example, the likely
response of the system to a change in a specific gene or protein. This is useful if one
wants to measure the impact of drugs on the behavior of the system. The use of available
expression data by analyzing the expression of the gene target and the identification of
co-expressed genes can provide a solution to this issue. This analysis is an interesting
direction for future research.
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proteins which are potential drug targets. As the disease is a balance between bacterial
pathogen virulence and host resistance, knocking out a given protein within the parasite
may adversely impact the host system. This means that for a drug target to be effective
it must take into account the host system. There is therefore a need to consider the host
system in order to produce a comprehensive map of protein interactions between pathogen
and the human host. The exploration of this map can yield drug targets which also con-
sider the host system to prevent potential adverse reactions in the host. This issue will be
addressed by a future research study.
3. We used the “LAMP” system (Linux, Apache, MySQL and PHP/Python) for imple-
menting our system and constructing an MTB strain CDC1551 protein interaction database
with interactive visualization provided via a web interface. This may be extended to in-
clude other strains, such as H37Rv, H37Ra, as well as other organisms, which would enable
a systems analysis of these organisms, as well as comparative genomic analysis. This can
help in the process of validating experiments and also serve to reduce the scale of further
high throughput screening for these organisms too. The design and implementation of such
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